<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7731292</article-id><article-id pub-id-type="doi">10.3390/molecules25235768</article-id><article-id pub-id-type="publisher-id">molecules-25-05768</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title><italic>Ferula</italic> L. Plant Extracts and Dose-Dependent Activity of Natural Sesquiterpene Ferutinin: From Antioxidant Potential to Cytotoxic Effects</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Macr&#x000ec;</surname><given-names>Roberta</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref><xref rid="c1-molecules-25-05768" ref-type="corresp">*</xref><xref ref-type="author-notes" rid="fn1-molecules-25-05768">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Musolino</surname><given-names>Vincenzo</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref><xref rid="c1-molecules-25-05768" ref-type="corresp">*</xref><xref ref-type="author-notes" rid="fn1-molecules-25-05768">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Gliozzi</surname><given-names>Micaela</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref></contrib><contrib contrib-type="author"><name><surname>Carresi</surname><given-names>Cristina</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref></contrib><contrib contrib-type="author"><name><surname>Maiuolo</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref></contrib><contrib contrib-type="author"><name><surname>Nucera</surname><given-names>Saverio</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref></contrib><contrib contrib-type="author"><name><surname>Scicchitano</surname><given-names>Miriam</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref></contrib><contrib contrib-type="author"><name><surname>Bosco</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref></contrib><contrib contrib-type="author"><name><surname>Scarano</surname><given-names>Federica</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref></contrib><contrib contrib-type="author"><name><surname>Ruga</surname><given-names>Stefano</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref></contrib><contrib contrib-type="author"><name><surname>Zito</surname><given-names>Maria Caterina</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref></contrib><contrib contrib-type="author"><name><surname>Guarnieri</surname><given-names>Lorenza</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref></contrib><contrib contrib-type="author"><name><surname>Bombardelli</surname><given-names>Ezio</given-names></name><xref ref-type="aff" rid="af2-molecules-25-05768">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0392-7173</contrib-id><name><surname>Mollace</surname><given-names>Vincenzo</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05768">1</xref><xref ref-type="aff" rid="af2-molecules-25-05768">2</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Capasso</surname><given-names>Raffaele</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-05768"><label>1</label>Institute of Research for Food Safety &#x00026; Health IRC-FSH, University Magna Graecia, 88100 Catanzaro, Italy; <email>micaela.gliozzi@gmail.com</email> (M.G.); <email>carresi@unicz.it</email> (C.C.); <email>jessicamaiuolo@virgilio.it</email> (J.M.); <email>saverio.nucera@hotmail.it</email> (S.N.); <email>miriam.scicchitano@hotmail.it</email> (M.S.); <email>boscofrancesca.bf@libero.it</email> (F.B.); <email>federicascar87@gmail.com</email> (F.S.); <email>rugast1@gmail.com</email> (S.R.); <email>mariacaterina.zito@studenti.unicz.it</email> (M.C.Z.); <email>lorenzacz808@gmail.com</email> (L.G.); <email>mollace@libero.it</email> (V.M.)</aff><aff id="af2-molecules-25-05768"><label>2</label>Nutramed S.c.a.r.l., Complesso Nin&#x000ec; Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy; <email>ezio.bombardelli@plantexresearch.it</email></aff><author-notes><corresp id="c1-molecules-25-05768"><label>*</label>Correspondence: <email>robertamacri85@gmail.com</email> (R.M.); <email>xabaras3@hotmail.com</email> (V.M.); Tel./Fax: +39-0961-3694301 (R.M. &#x00026; V.M.)</corresp><fn id="fn1-molecules-25-05768"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2020</year></pub-date><volume>25</volume><issue>23</issue><elocation-id>5768</elocation-id><history><date date-type="received"><day>10</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>06</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The employment studies of natural extracts in the prevention and treatment of several diseases highlighted the role of different species of genus <italic>Ferula</italic> L., belonging to the Apiaceae family, dicotyledonous plants present in many temperate zones of our planet. <italic>Ferula communis</italic> L. is the main source of sesquiterpene ferutinin, a bioactive compound studied both in vitro and in vivo, because of different effects, such as phytoestrogenic, antioxidant, anti-inflammatory, but also antiproliferative and cytotoxic activity, performed in a dose-dependent and cell-dependent way. The present review will focus on the molecular mechanisms involved in the different activities of Ferutinin, starting from its antioxidant potential at low doses until its ionophoric property and the subsequent mitochondrial dysfunction induced through administration of high doses, which represent the key point of its anticancer action. Furthermore, we will summarize the data acquired from some experimental studies on different cell types and on several diseases. The results obtained showed an important antioxidant and phytoestrogenic regulation with lack of typical side effects related to estrogenic therapy. The preferential cell death induction for tumor cell lines suggests that ferutinin may have anti-neoplastic properties, and may be used as an antiproliferative and cytotoxic agent in an estrogen dependent and independent manner. Nevertheless, more data are needed to clearly understand the effect of ferutinin in animals before using it as a phytoestrogen or anticancer drug.</p></abstract><kwd-group><kwd><italic>Ferula</italic> L.</kwd><kwd>ferutinin</kwd><kwd>antioxidant and anti-inflammatory potential</kwd><kwd>phytoestrogenic activity</kwd><kwd>ionophoric property</kwd><kwd>mitochondrial dysfunction</kwd><kwd>ROS</kwd><kwd>NO</kwd><kwd>antiproliferative and cytotoxic activity</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-05768"><title>1. Introduction</title><p>The use of herbal and plants extracts to prevent and to treat several acute and chronic diseases is an object of growing interest and investigation in pharmacological and nutraceutical research [<xref rid="B1-molecules-25-05768" ref-type="bibr">1</xref>,<xref rid="B2-molecules-25-05768" ref-type="bibr">2</xref>,<xref rid="B3-molecules-25-05768" ref-type="bibr">3</xref>].</p><p>In vitro and in vivo evidence showed that the bioactive compounds isolated from herbs and plants showed antioxidant, anti-inflammatory and anti-cancer property [<xref rid="B4-molecules-25-05768" ref-type="bibr">4</xref>,<xref rid="B5-molecules-25-05768" ref-type="bibr">5</xref>,<xref rid="B6-molecules-25-05768" ref-type="bibr">6</xref>]. </p><p>The oxidative-stress reduction leads to a decreased risk of onset of several pathologies, such as cancer and chronic inflammatory diseases [<xref rid="B7-molecules-25-05768" ref-type="bibr">7</xref>]. Among these the phenolic plants, classified into flavonoids, phenolic acids, stilbenes, tannins and lignans exert antioxidant activity in vivo and in vitro [<xref rid="B8-molecules-25-05768" ref-type="bibr">8</xref>,<xref rid="B9-molecules-25-05768" ref-type="bibr">9</xref>]; the stress oxidative reduction is due to their aromatic rings that contains hydroxyl groups and the antioxidant capacity depends on the number of these groups [<xref rid="B10-molecules-25-05768" ref-type="bibr">10</xref>]. In particular, it has been observed that the flavonoid fraction of bergamot, an endemic plant of Calabrian region, showed pleiotropic effects reducing oxidative stress and cellular and tissue inflammation [<xref rid="B11-molecules-25-05768" ref-type="bibr">11</xref>,<xref rid="B12-molecules-25-05768" ref-type="bibr">12</xref>,<xref rid="B13-molecules-25-05768" ref-type="bibr">13</xref>]. Furthermore, in vitro evidence suggests that another group of bioactive compounds, extracted from herbs, plants and fruits, such as monoterpenes, sesquiterpenes and diterpenes have antioxidant properties [<xref rid="B14-molecules-25-05768" ref-type="bibr">14</xref>,<xref rid="B15-molecules-25-05768" ref-type="bibr">15</xref>]. Indeed, the sesquiterpenes may play an important activity in human diseases, having anti-cancer [<xref rid="B16-molecules-25-05768" ref-type="bibr">16</xref>], anti-inflammatory [<xref rid="B17-molecules-25-05768" ref-type="bibr">17</xref>,<xref rid="B18-molecules-25-05768" ref-type="bibr">18</xref>], bactericidal properties [<xref rid="B19-molecules-25-05768" ref-type="bibr">19</xref>].</p><p>The results obtained in different experimental works suggest that the sesquiterpenes have protective potential at low doses and cause severe toxic effects at high doses [<xref rid="B20-molecules-25-05768" ref-type="bibr">20</xref>]; this bipolar effect is due to the increases, induced by sesquiterpenes, of the cation permeability of lipid bilayers and mitochondrial membrane in a dose-dependent manner with a higher selectivity for divalent cations, such as calcium ions which play a key role in several pathophysiological processes [<xref rid="B21-molecules-25-05768" ref-type="bibr">21</xref>,<xref rid="B22-molecules-25-05768" ref-type="bibr">22</xref>,<xref rid="B23-molecules-25-05768" ref-type="bibr">23</xref>]. </p><p>Among the plants richest in sesquiterpenes and their derivatives, the genus <italic>Ferula</italic> L. is one of the most representative [<xref rid="B24-molecules-25-05768" ref-type="bibr">24</xref>].</p></sec><sec id="sec2-molecules-25-05768"><title>2. <italic>Ferula communis</italic> L.: Botanical Description and Chemical Composition</title><p>The genus <italic>Ferula</italic> L. belongs to the <italic>Apiacae</italic> family dycotiledonus plants comprising more than 400 genera and about 3700 species. This genus consists of about 170 species which mainly grow in the Mediterraneus zones, Northern Africa and Central Asia [<xref rid="B24-molecules-25-05768" ref-type="bibr">24</xref>]. In Italy, three species have been described i.e., <italic>Ferula communis</italic> L., <italic>Ferula glauca</italic> L. and <italic>Ferula arrigonii</italic> Bocchieri. </p><p>Particularly, in the Calabrian region, only one species, i.e., <italic>Ferula communis</italic> L., has been reported. <italic>Ferula communis</italic> L., vulgarly known as giant fennel is a perennial growing to about 3 m by 1 m herbaceous species [<xref rid="B25-molecules-25-05768" ref-type="bibr">25</xref>]. The lower leaves are 3 to 4 pinnates, triangular, varied in size, soft, glabrous, green on both sides and usually have a conspicuous sheathing base. The lamina is finely divided into linear and filiform lobes. The latter have no distinct revolute margin and are up to 50 mm long, but no more than 1 mm. wide. The upper fertile leaves of the inflorescence are progressively reduced to a conspicuous sheathing base. The bracts are absent and the bracteoles are few or absent. The stem is very robust, wide (3&#x02013;7 cm in diameter), full, finely striated and can grow to 2 to 3 meters high. The terminal fertile umbel is large and composed of 20 to 40 rays. The flower is bright yellow. The fruit (mericap) is elliptical or oblong-elliptical, strongly compressed dorsally; the length is varied between 7 and 15 mm [<xref rid="B26-molecules-25-05768" ref-type="bibr">26</xref>,<xref rid="B27-molecules-25-05768" ref-type="bibr">27</xref>]. </p><p>This herbaceous plant presents different pharmaceutical activities related to different content of bioactive compounds extracted mainly from the roots, but also from the leaves and the rhizome. Indeed, there are two different chemotypes, which differs mainly for the produced effects. The toxic chemotype have a high percentage of ferulenol, a prenylated coumarin compound that leads to ferulosis, a lethal hemorrhagic syndrome in animals and humans [<xref rid="B28-molecules-25-05768" ref-type="bibr">28</xref>]. The traditional use of non-toxic chemotype of <italic>F. communis</italic> L. is related to care of skin diseases, microbial and fungal infections, hysteria and dysentery [<xref rid="B29-molecules-25-05768" ref-type="bibr">29</xref>].</p><p>The chromatographic analysis of non-toxic chemotype presents a high percentage of sesquiterpenes and their derivatives, such as ferutinin, lapiferin and teferin. The high concentration of ferutinin (ferutinol p-idroxybenzoate) is responsible for most of the effects produced by <italic>Ferula</italic> extract administration [<xref rid="B30-molecules-25-05768" ref-type="bibr">30</xref>]. </p><p>Ferutinin is a sesquiterpene, extracted from the roots, the leaves and the rhizome [<xref rid="B31-molecules-25-05768" ref-type="bibr">31</xref>,<xref rid="B32-molecules-25-05768" ref-type="bibr">32</xref>]. Different mechanisms by which several compounds, isolated from many species of <italic>Ferula</italic> L., exert their inhibitory activity on cell growth are known [<xref rid="B33-molecules-25-05768" ref-type="bibr">33</xref>]. Among the compounds isolated from many species of <italic>Ferula</italic>, ferutinin obtained from the plants <italic>Ferula ovina</italic> Boiss., <italic>Ferula communis</italic> L., <italic>Ferula hermonis</italic> Boiss., and other species of <italic>Ferula</italic> [<xref rid="B34-molecules-25-05768" ref-type="bibr">34</xref>,<xref rid="B35-molecules-25-05768" ref-type="bibr">35</xref>], is known for the different activities that, in a dose-dependent way, performs both in vitro and in vivo (<xref ref-type="fig" rid="molecules-25-05768-f001">Figure 1</xref>). In particular, ferutinin has shown estrogenic, anti-inflammatory, antiproliferative, cytotoxic [<xref rid="B36-molecules-25-05768" ref-type="bibr">36</xref>], antifungal and antimicrobial activities; the cytotoxic activity represents the pivotal role of its action that should leads to the use of this molecule in anti-neoplastic therapy [<xref rid="B37-molecules-25-05768" ref-type="bibr">37</xref>,<xref rid="B38-molecules-25-05768" ref-type="bibr">38</xref>,<xref rid="B39-molecules-25-05768" ref-type="bibr">39</xref>,<xref rid="B40-molecules-25-05768" ref-type="bibr">40</xref>].</p></sec><sec id="sec3-molecules-25-05768"><title>3. Antioxidant Potential of Low Doses of Ferutinin</title><p>Low doses of ferutinin and other sesquiterpenes mimic the action of many antioxidant molecules, such as flavonoids and phenolic acids [<xref rid="B8-molecules-25-05768" ref-type="bibr">8</xref>,<xref rid="B9-molecules-25-05768" ref-type="bibr">9</xref>,<xref rid="B41-molecules-25-05768" ref-type="bibr">41</xref>].</p><p>It has been demonstrated that low doses of ferutinin are associated with a strong antioxidant, anti-inflammatory and anti-tumorigenic activity [<xref rid="B42-molecules-25-05768" ref-type="bibr">42</xref>,<xref rid="B43-molecules-25-05768" ref-type="bibr">43</xref>], in fact the sesquiterpenes oxidize over time into sesquiterpenols, leading to a reduction of cellular oxidative status. In accordance, the results obtained in different experimental works suggest a key role of low doses of ferutinin in the reduction of free radicals production. This, in turn, determines an increase of antioxidant enzymes and glutathione and a decrease of inflammation [<xref rid="B42-molecules-25-05768" ref-type="bibr">42</xref>,<xref rid="B43-molecules-25-05768" ref-type="bibr">43</xref>]. </p><p>In particular, an in vivo study demonstrated that products extracted from neuroactive endogenous medicinal plants, including ferutinin, are possible neuromodulators, with potential anticonvulsant properties at low doses. Indeed, these compounds, as observed for phenolic acids which in vitro and in vivo modulate the inhibitory action of glycine receptor, proved to be potential scavengers fighting against the range of neurodegenerative diseases by improving body antioxidant potential [<xref rid="B43-molecules-25-05768" ref-type="bibr">43</xref>]. </p><p>Raafat et al. (2015) studied the potential in vivo antioxidant and antihyperglicemic activity of <italic>Ferula</italic> extracts, including ferutinin at low doses (0.4&#x02013;0.8&#x02013;1.6 mg/Kg). At concentration of 1.6 mg/Kg, ferutinin was able to cause a significant glucose levels decrease and body weight increase in treated-mice respect to diabetic control group. Furthermore, consistent with previous experimental studies [<xref rid="B44-molecules-25-05768" ref-type="bibr">44</xref>], it was observed that the same concentration of ferutinin administration significantly reverted the reduction trend of antioxidant enzyme catalase expression observed in diabetic mice. In addition to this evidence, this study for the first time described the antioxidant effects of ferutinin on neuropathic pain associated with diabetes, showing that 1.6 mg/Kg of ferutinin led to attenuation of tactile allodynia and thermal hyperalgesia [<xref rid="B45-molecules-25-05768" ref-type="bibr">45</xref>].</p></sec><sec id="sec4-molecules-25-05768"><title>4. Phytoestrogenic Activity of Ferutinin and the Hormone Replacement Therapy (HRT)</title><p>HRT is widely used to control menopausal symptoms and to prevent osteoporosis and dementia in women. However, its potential prothrombotic effects with a significant increased risk of venous thromboembolism and myocardial infarction led to evaluate the use of alternative estrogenic-therapy having the same efficacy, but with the reduction of side effects HRT-associated [<xref rid="B46-molecules-25-05768" ref-type="bibr">46</xref>].</p><p>Several data highlighted that ferutinin could be an effective alternative hormone therapy to prevent and treat post-menopausal symptoms, since this sesquiterpene is able to mime the endocrine activity of the ovaries [<xref rid="B47-molecules-25-05768" ref-type="bibr">47</xref>,<xref rid="B48-molecules-25-05768" ref-type="bibr">48</xref>]. Thus, thanks to its similarity of structure with steroid hormones, ferutinin has been classified as a phytoestrogen with an affinity for both estrogen receptors subtypes ER&#x003b1; and ER&#x003b2; and for the G protein-coupled estrogen receptor (GPER) [<xref rid="B49-molecules-25-05768" ref-type="bibr">49</xref>]. </p><p>ER&#x003b1; and ER&#x003b2; receptors are transcribed from different genes and their expression is cell-type and tissue-type dependent. The nuclear estrogen receptors activate signalling pathway that result in the expression control of several genes by the direct binding to gene promoters or specific DNA sequences, called estrogen response elements (EREs). These palindromic sequences are located into the regulatory regions of target genes [<xref rid="B50-molecules-25-05768" ref-type="bibr">50</xref>], such as the genes encoding the estrogen-responsive finger protein (EFP), which are strongly expressed in breast cancer, and the estrogen receptor-binding fragment-associated antigen 9 (EBAG9). Several transcription factors (TP53, FOS, JUN), secreted proteins (C3, AGT, LTF), proteins of intracellular signaling (BRCA1, BCL2, HRAS) are directly regulated by estrogenic action [<xref rid="B51-molecules-25-05768" ref-type="bibr">51</xref>]. Instead, the GPER receptors are associated with a rapid cellular signaling, inducing cAMP production, ions mobilization, kinases activation, such as ERK1/2 and PI3K/Akt. In addition, GPER receptors regulates both calcium and potassium channels and are able to activate endothelial nitric oxide synthase (eNOS) with the subsequent maintenance of physiological nitric oxide (NO) production and, consequently, of endothelial function [<xref rid="B52-molecules-25-05768" ref-type="bibr">52</xref>]. Overall, the possible activation of these mechanisms might justify the use of ferutinin as a more safe approach for the control of menopausal symptoms than &#x0201c;classical&#x0201d; HRT [<xref rid="B47-molecules-25-05768" ref-type="bibr">47</xref>,<xref rid="B48-molecules-25-05768" ref-type="bibr">48</xref>].</p><p>In vitro, the ferutinin binding affinity shows an inversion compared to other phytoestrogens since it has a greater affinity for estrogenic receptor ER&#x003b1; than for ER&#x003b2; [<xref rid="B49-molecules-25-05768" ref-type="bibr">49</xref>]; the in vivo phytoestrogenic activity confirms this binding specificity as, at the hypothalamic level, it has been observed a modulated expression of the ER&#x003b1; receptor [<xref rid="B53-molecules-25-05768" ref-type="bibr">53</xref>]. It has been observed that ferutinin, when administered alone, increases the expression of ER&#x003b1;, while, when co-administered concomitantly with estradiol, decreases its expression [<xref rid="B50-molecules-25-05768" ref-type="bibr">50</xref>,<xref rid="B54-molecules-25-05768" ref-type="bibr">54</xref>]. Additional evidence demonstrated that ferutinin exerts an action comparable to estradiol benzoate, stimulating the endometrial proliferation. Moreover, ferutinin, dissimilar to estrogens, is able to increase the apoptotic index in luminal and glandular epithelia, avoiding the consequent stimulation of excessive cell proliferation leading to endometrial cancer. This represents an important goal because it might overcome the main risks related to the HRT [<xref rid="B55-molecules-25-05768" ref-type="bibr">55</xref>].</p><p>In vivo studies also shown that ferutinin prevents osteoporosis and exhibits dose-dependent osteoprotective effects. Indeed, different doses of ferutinin exerted an important activity on bone remodelling in rats ovariectomized which reflects the effects of estrogen deficiency in menopause women [<xref rid="B48-molecules-25-05768" ref-type="bibr">48</xref>,<xref rid="B56-molecules-25-05768" ref-type="bibr">56</xref>,<xref rid="B57-molecules-25-05768" ref-type="bibr">57</xref>]. In these experimental works the histomorphometric analysis of cortical bone of femoral diaphysis and of vertebral bodies, specifically the trabecular bone of lumen vertebrae and distal femoral epiphysis has been performed. The data obtained showed that the ovariectomized rats orally treated with ferutinin (2 mg/Kg/day for 60 days) showed the same bone mass values of ovariectomized rats treated with estradiol benzoate [<xref rid="B54-molecules-25-05768" ref-type="bibr">54</xref>,<xref rid="B56-molecules-25-05768" ref-type="bibr">56</xref>]. Another in vivo study conducted in ovariectomized rats, treated with the same concentration of ferutinin (2 mg/Kg/day for 60 days), it has been showed that ferutinin exerts an important action on body weight and bone loss, since the administration of this molecule is able to prevent together the excessive gain of weight and the osteoporosis caused by estrogen deficiency [<xref rid="B56-molecules-25-05768" ref-type="bibr">56</xref>].</p><p>Furthermore, a recent study showed that ferutinin, through the regulation of Wnt/&#x003b2; catenin pathway, was able to promote osteogenic differentiation of dental pulp-derived stem cells, with a consequent promotion of bone density, acting on the promoter regions of Wnt Family Member 3A (<italic>WNT3A)</italic> and disheveled segment polarity protein 3 (<italic>DVL3)</italic>, by the activation of H3K9 acetylation and H3K4 trimethylation (not shown), upregulating their expression, as well as that of low-density lipoprotein receptor-related protein 6 (<italic>LRP6</italic>); instead ferutinin leads the downregulation of the expression of glycogen synthase kinase-3 (<italic>GSK3)</italic>. It is known that in the absence of <italic>WNT, GSK3</italic> constitutively phosphorylates the &#x003b2;-catenin and leads its ubiquitination and proteosomal degradation. However, in the presence of the ligand <italic>WNT</italic> and the binding of <italic>WNT</italic> protein to their receptor-co-receptor complexes (<italic>Frizzled-LRP</italic>), disheveled is activated and inhibits the phosphorylation of beta catenin by <italic>GSK3</italic>. The downregulation of <italic>GSK3</italic> expression is also associated with an inhibition of adipogenic process through the regulatory axis of <italic>GSK3/STAT5/Sfrp/Wnt</italic>. This evidence leads to hypothesize a potential role for Ferutinin as epigenetic activator and modulator of stem cells therapy to counteract osteoporosis (<xref ref-type="fig" rid="molecules-25-05768-f002">Figure 2</xref>) [<xref rid="B58-molecules-25-05768" ref-type="bibr">58</xref>]. </p><sec><title>Phytoestrogenic and Ionophoric Activity of Ferutinin: Effects on Platelet Aggregation</title><p>The ionoforic effects of ferutinin on platelets are in contrast to the other calcium ionophores; indeed, the standard ionophores produce a collapse of membrane ionic gradient in different cellular compartments, due to the calcium ions release from mitochondria, whereas ferutinin acts similar to an electrogenic uniporter and induces increased concentrations of cytosolic calcium, through the calcium release from endoplasmic reticulum, and a subsequent accumulation in mitochondria [<xref rid="B59-molecules-25-05768" ref-type="bibr">59</xref>]. The intracellular calcium ions, in turn, increase plays a key role in different steps of platelet activation, firstly in the shape change and subsequently in platelet aggregation mechanisms [<xref rid="B59-molecules-25-05768" ref-type="bibr">59</xref>,<xref rid="B60-molecules-25-05768" ref-type="bibr">60</xref>,<xref rid="B61-molecules-25-05768" ref-type="bibr">61</xref>]. </p><p>In this context, the peculiar activity of ferutinin might be due to the association with the prominent affinity of ferutinin for estrogen receptors GPER, which are present on the platelet membranes [<xref rid="B59-molecules-25-05768" ref-type="bibr">59</xref>,<xref rid="B62-molecules-25-05768" ref-type="bibr">62</xref>,<xref rid="B63-molecules-25-05768" ref-type="bibr">63</xref>]. In fact, the estrogenic regulation of platelets is independent of genomic regulation exerted by nuclear receptors ER&#x003b1; and ER&#x003b2;, since the platelet are anuclear blood elements.</p><p>In this regard, the experimental studies conducted by Zamaraeva et al. (2010) demonstrated that the ionophoric activity that ferutinin exerts on calcium ions, going to up-regulate the latter, activating the fibrinogen receptors and increasing their binding, does not produce effects on spontaneous platelet aggregation [<xref rid="B59-molecules-25-05768" ref-type="bibr">59</xref>,<xref rid="B64-molecules-25-05768" ref-type="bibr">64</xref>,<xref rid="B65-molecules-25-05768" ref-type="bibr">65</xref>]. </p><p>Two hypotheses have been advanced to explain these results. The first regards the evidence that the ionophoric activity of ferutinin in platelet is able to stimulate the calcium-dependent NOS and the subsequent increase of NO; the NO elevation, through the cAMP and cGMP signaling, in turn, could directly and indirectly induce the calcium ions accumulation into the intracellular stores, reducing the calcium ions in platelets [<xref rid="B59-molecules-25-05768" ref-type="bibr">59</xref>,<xref rid="B66-molecules-25-05768" ref-type="bibr">66</xref>]. The second highlights that the cAMP level increase could follow the interaction with ferutinin and the estrogen receptor coupled to G-protein found on the platelet plasma membrane [<xref rid="B59-molecules-25-05768" ref-type="bibr">59</xref>].</p><p>This evidence suggests that the activation of downstream intracellular signaling pathways of GPER within the platelet membrane could represent a potential target to develop new therapeutic strategies to prevent thrombosis and arterial ischemic events [<xref rid="B67-molecules-25-05768" ref-type="bibr">67</xref>].</p></sec></sec><sec id="sec5-molecules-25-05768"><title>5. High Concentrations of Ferutinin: Pro-Oxidant and Cytotoxic Activity</title><p>At high concentrations, ferutinin triggers the overproduction of reactive oxygen species (ROS) in mitochondria, such as superoxide anion, at the level of the respiratory chain subunits I and III, through the opening induction of calcium channels and the subsequent alteration of the trans-membrane potential [<xref rid="B36-molecules-25-05768" ref-type="bibr">36</xref>]. The increase in ROS produces different cell type dependent effects, both by promoting the oncogenes activation and the cancer initiation and progression [<xref rid="B68-molecules-25-05768" ref-type="bibr">68</xref>], and by activating the intrinsic apoptotic pathway of caspase-9, producing an additive effect on cell death induction [<xref rid="B69-molecules-25-05768" ref-type="bibr">69</xref>,<xref rid="B70-molecules-25-05768" ref-type="bibr">70</xref>]. </p><p>A growing number of data shows that many bioactive natural compounds lead to increase the ROS production and the related oxidative stress, with the subsequent activation of apoptosis pathway in tumor cell lines [<xref rid="B71-molecules-25-05768" ref-type="bibr">71</xref>,<xref rid="B72-molecules-25-05768" ref-type="bibr">72</xref>]. </p><p>This increase seems to have a specific selectivity for the cancer cells compared to healthy cells: indeed, it has been observed a ferutinin-induced biphasic increase in intracellular calcium in T-leukemia cell line Jurkat. The plasma membrane of human lymphocyte expresses non-voltage-gated L-type calcium channels which have a crucial role in the biphasic calcium flux: the initial observed peak through the calcium mobilization from intracellular stores was maintained thanks the entry of extracellular calcium through the L-type calcium channels [<xref rid="B61-molecules-25-05768" ref-type="bibr">61</xref>,<xref rid="B73-molecules-25-05768" ref-type="bibr">73</xref>]. </p><p>A recent study, using isolated rat liver mitochondria, aimed to evaluate the mitochondrial damages produced by ferutinin and demonstrated that the latter, was able to decrease the organelle respiration at concentration of 5&#x02013;27 &#x000b5;M and to determine the membrane potential dissipation at concentration of 10&#x02013;60 &#x000b5;M in a dose-dependent manner. It has also been observed that the mitochondrial effects of ferutinin might be primarily induced by stimulation of Ca<sup>2+</sup>-permeability, but different mechanisms, such as a driving of univalent cations, might be involved [<xref rid="B74-molecules-25-05768" ref-type="bibr">74</xref>]. </p><p>Furthermore, ferutinin, thanks to phytoestrogenic property, acts by enhancing the activity of NOS [<xref rid="B75-molecules-25-05768" ref-type="bibr">75</xref>,<xref rid="B76-molecules-25-05768" ref-type="bibr">76</xref>], through the increase of intracellular calcium [<xref rid="B65-molecules-25-05768" ref-type="bibr">65</xref>]. The NOS presents three different isoenzymes that catalyse the production of the NO, a molecule that plays two divergent roles depending on the concentration [<xref rid="B77-molecules-25-05768" ref-type="bibr">77</xref>,<xref rid="B78-molecules-25-05768" ref-type="bibr">78</xref>]: in fact, the NO, at low concentrations, is involved in the cell viability processes performing its physiological functions at the neuronal, placental and endothelial level, while at high concentrations and for prolonged time, triggers cellular toxicity mechanisms going to activate different pathways of cell death, cell growth arrest and excitotoxicity [<xref rid="B79-molecules-25-05768" ref-type="bibr">79</xref>]. </p><p>The NO production, indeed, presents cell-specificity and dose-dependent effects [<xref rid="B80-molecules-25-05768" ref-type="bibr">80</xref>], promoting apoptosis through mitochondrial dysfunction leading to release of pro-apoptotic factors, such as cytochrome c from the organelles [<xref rid="B81-molecules-25-05768" ref-type="bibr">81</xref>]. </p><p>Moreover, the NO bounds and inhibits the cytochrome c oxidase that leads to ROS overproduction, the consequent formation of peroxynitrite, that oxidizing and damaging irreversibly all mitochondrial complexes, affects the correct mitochondrial respiration triggering apoptosis (<xref ref-type="fig" rid="molecules-25-05768-f003">Figure 3</xref>) [<xref rid="B82-molecules-25-05768" ref-type="bibr">82</xref>,<xref rid="B83-molecules-25-05768" ref-type="bibr">83</xref>]. </p><p>Increasing evidence on the ability of ferutinin to inhibit cell growth and to induce apoptosis both in vitro and in vivo [<xref rid="B79-molecules-25-05768" ref-type="bibr">79</xref>] has led to a growing of research on ferutinin as an anti-cancer and chemopreventive agent, both alone and in combination with other chemotherapeutic drugs [<xref rid="B84-molecules-25-05768" ref-type="bibr">84</xref>,<xref rid="B85-molecules-25-05768" ref-type="bibr">85</xref>,<xref rid="B86-molecules-25-05768" ref-type="bibr">86</xref>,<xref rid="B87-molecules-25-05768" ref-type="bibr">87</xref>,<xref rid="B88-molecules-25-05768" ref-type="bibr">88</xref>]. In particular, ferutinin had shown pro-apoptotic properties on several cell lines mediated by mitochondrial permeabilization and the release of molecules implicated in intrinsic apoptotic induction and progression. Among them, apoptosis inducing factor (AIF), a mitochondrial oxide-reductase, exerted a relevant role as physiologically participates in the electronic transport and, once it has released from the mitochondrion, moves into the nucleus acting as DNAse [<xref rid="B89-molecules-25-05768" ref-type="bibr">89</xref>]. </p><p>In addition, the SMAC/DIABLO molecule, inhibitor of the inhibitors of apoptosis proteins (IAPs), might be involved in the mechanism of ferutinin toxicity, as once leaked from the mitochondria, it can bind IAP, preventing the inhibition of caspase activity and promoting the formation and activation of the apoptosome complex, leading to caspase-9 activation [<xref rid="B90-molecules-25-05768" ref-type="bibr">90</xref>,<xref rid="B91-molecules-25-05768" ref-type="bibr">91</xref>] that is considered an initiator of a cascade of caspases. The effector caspases 6 and 7, in turn, once activated, cleave different substrates, such as laminin, actin, vimentin and ICAD (<xref ref-type="fig" rid="molecules-25-05768-f004">Figure 4</xref>) [<xref rid="B92-molecules-25-05768" ref-type="bibr">92</xref>], causing apoptotic cell death.</p><p>Among cell lines tested to verify ferutinin effects, it was observed that, for tumor cell lines, human breast adenocarcinoma cell line (MCF-7), human cells of urothelial carcinoma (TCC), human colon adenocarcinoma cells (HT29), murine cells of colon carcinoma (CT26), IC 50 was between 67 and 81 &#x003bc;M, while the IC 50 for normal human and murine fibroblast lines (HFF3 and NIH/3T3) was higher, with values of 98 and 136 &#x003bc;M respectively, with about 67% of viable cells in both cell lines treated at the above concentrations (<xref rid="molecules-25-05768-t001" ref-type="table">Table 1</xref>) [<xref rid="B32-molecules-25-05768" ref-type="bibr">32</xref>,<xref rid="B33-molecules-25-05768" ref-type="bibr">33</xref>,<xref rid="B34-molecules-25-05768" ref-type="bibr">34</xref>,<xref rid="B35-molecules-25-05768" ref-type="bibr">35</xref>,<xref rid="B36-molecules-25-05768" ref-type="bibr">36</xref>]. Another study conducted by Alkhatib et al. (2008) showed that the ferutinin produced cytotoxic effects on (imatinib-resistant) human chronic myeloid leukemia cell line (K562R) and (dasatinib-resistant) mouse leukemia cell lines (DA1-3b/M2BCR-ABL), respectively at IC 50 25.3 &#x003bc;M and 29.1 &#x003bc;M [<xref rid="B93-molecules-25-05768" ref-type="bibr">93</xref>].</p><p>Furthermore, Arghiani et al. (2015) observed cytotoxic effects of ferutinin on human teratocarcinoma (NTERA2) and oesophageal cancer (KYSE30) cell lines and the IC50 values were respectively 39 &#x003bc;M and 58 &#x003bc;M [<xref rid="B94-molecules-25-05768" ref-type="bibr">94</xref>].</p><p>The anti-cancer ferutinin activity was also evaluated in vivo, in comparison with cisplatin, on tumors developed in hybrid BALB/C mice: a tumor reduction of 67% for ferutinin and of 72% for cisplatin was observed; however while the latter produced a significant alteration of the liver tissues and the spleen of the treated mice, this did not happen for mice in treatment with ferutinin [<xref rid="B95-molecules-25-05768" ref-type="bibr">95</xref>]. </p><p>In vitro studies have shown that, thanks to its phytoestrogenic activity, ferutinin induced the inhibition of proliferation in human breast carcinoma MCF-7 cells [<xref rid="B96-molecules-25-05768" ref-type="bibr">96</xref>]. To test whether ferutinin actually acts as a protective agent on breast and uterine carcinoma, two different mechanisms involved in the initiation and in the progression of cancer, respectively, were assessed. The first was the evaluation of the cell proliferation rate through the Ki-67 antigen, a non-histone nuclear protein used as a good proliferation marker, as it is present at low levels in the quiescent cells and increases in proliferating cells, especially in phase G2, M and in the second half of phase S. The second was the detection of DNA fragments generating during the apoptotic process [<xref rid="B97-molecules-25-05768" ref-type="bibr">97</xref>]. These studies showed that ferutinin produced dose-dependent effects and, in particular, the oral dose of 2 mg/kg/day offered the best protective action, increasing the rate of apoptosis in the glandular epithelia of ovariectomized rats [<xref rid="B97-molecules-25-05768" ref-type="bibr">97</xref>]. In addition, ferutinin showed its antiproliferative activity on human and murine leukemia cell lines [<xref rid="B93-molecules-25-05768" ref-type="bibr">93</xref>].</p><p>A recent study confirmed the cytotoxic activity of ferutinin also on the prostate cancer (PC-3) cell-line, with IC 50 values of 16.7 &#x000b5;M. The low IC 50 is due to the cross-link among the cytotoxic activity and hormonal action, since the prostate cancer onset is primarily due to androgenic hormones [<xref rid="B98-molecules-25-05768" ref-type="bibr">98</xref>].</p><p>Gao et al. (2013) showed that ferutinin, in a dose-dependent way and, particularly, at high concentrations (40 &#x003bc;M or above), was able to induce apoptosis in human red blood cells (RBCs), without the involvement of mitochondria since these cells lose those organells during the maturation process. The erythroptosis is mediated by simultaneous increase of the cytosolic free calcium ions level and the activity of caspase-3. In addition, the external calcium depletion had not blocked the apoptosis mediated by ferutinin, suggesting that the existence of unknown mediators of apoptosis are ferutinin-induced, which could be added to the ionophoric activity [<xref rid="B99-molecules-25-05768" ref-type="bibr">99</xref>]. Certainly, this toxicity of ferutinin in vitro suggests that more studies on animals are needed to examine effect of ferutinin before evaluating it as a phytoestrogen or anticancer drug.</p></sec><sec sec-type="conclusions" id="sec6-molecules-25-05768"><title>6. Conclusions and Futures Perspectives</title><p>The <italic>Ferula</italic> genus extract contains a high percentage of the bioactive compound ferutinin, having a wide range of biological effects that elect it as a possible therapeutic agent with a broad spectrum of action. We examined the effects of ferutinin, highlighting the deep gap existing between the uses of high and low doses.</p><p>Indeed, the ferutinin administration at low-concentration is associated with an important antioxidant action, although the mechanisms of free radical decrease still need further clarification.</p><p>Moreover, the effects of cross-talk between the estrogenic and ionophoric properties of ferutinin that lead to strongly reduction of the side effects produced by usual estrogen therapy, allow this molecule to be eligible as a potential therapeutic agent in the gynecological pathologies. </p><p>Concerning the antiproliferative action of ferutinin, several in vitro and in vivo studies showed that the bioactive compound acts both on cytotoxicity and cell proliferation in an estrogen-dependent and -independent manner and its activity is dose dependent and variable according to the cell type analysed, with a preferential action for tumor cell lines.</p><p>The ionophoric effect of ferutinin with the consequent loss of the trans-membrane potential seems to be the key point of the antiproliferative and cytotoxic effect, both directly through the activation of mitochondrial-dependent apoptosis and indirectly through the effects produced by the summarization of NO and ROS, molecules that play a key role in the production of stress, senescence and death signals.</p><p>Therefore, based on the evidences obtained, the bioactive compound ferutinin can be considered an effective therapeutic agent as adjuvant or substitute for the current anti-neoplastic treatments. More studies should be performed to evaluate its action on other cell types and further molecular pathways involved, to compare its activity with that of chemotherapy drugs going to evaluate the different degree of toxicity produced as a side effect on healthy cells.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work has been supported by PON-MIUR 03PE000_78_1 and PONMIUR 03PE000_78_2. POR Calabria FESR FSE 2014&#x02013;2020 Asse 12-Azioni 10.5.6 e 10.5.12</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>V.M. (Vincenzo Mollace), R.M. and V.M. (Vincenzo Musolino) conceptualized and designed the manuscript; R.M. and V.M. (Vincenzo Musolino) wrote the manuscript; V.M. (Vincenzo Mollace) and M.G. revised the manuscript; R.M., C.C., M.S., F.S., F.B., S.N., J.M., S.R., M.C.Z. and L.G. contributed to the collection of data and to designing the tables and figures; E.B. edited the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>The work has been supported by the public resources from the Italian Ministry of Research.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-05768"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aye</surname><given-names>M.M.</given-names></name><name><surname>Aung</surname><given-names>H.T.</given-names></name><name><surname>Sein</surname><given-names>M.M.</given-names></name><name><surname>Armijos</surname><given-names>C.</given-names></name></person-group><article-title>A Review on the Phytochemistry Medicinal Properties and Pharmacological Activities of 15 Selected Myanmar Medicinal Plants</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>293</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24020293</pub-id><?supplied-pmid 30650546?><pub-id pub-id-type="pmid">30650546</pub-id></element-citation></ref><ref id="B2-molecules-25-05768"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gliozzi</surname><given-names>M.</given-names></name><name><surname>Walker</surname><given-names>R.</given-names></name><name><surname>Mollace</surname><given-names>V.</given-names></name></person-group><article-title>Bergamot Polyphenols: Pleiotropic Players in the Treatment of Metabolic</article-title><source>J. Metabolic. Synd.</source><year>2014</year><volume>3</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.4172/2167-0943.1000143</pub-id></element-citation></ref><ref id="B3-molecules-25-05768"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oppedisano</surname><given-names>F.</given-names></name><name><surname>Macr&#x000ec;</surname><given-names>R.</given-names></name><name><surname>Gliozzi</surname><given-names>M.</given-names></name><name><surname>Musolino</surname><given-names>V.</given-names></name><name><surname>Carresi</surname><given-names>C.</given-names></name><name><surname>Maiuolo</surname><given-names>J.</given-names></name><name><surname>Bosco</surname><given-names>F.</given-names></name><name><surname>Nucera</surname><given-names>S.</given-names></name><name><surname>Zito</surname><given-names>M.C.</given-names></name><name><surname>Guarnieri</surname><given-names>L.</given-names></name><etal/></person-group><article-title>The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection</article-title><source>Biomedicines</source><year>2020</year><volume>25</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines8090306</pub-id></element-citation></ref><ref id="B4-molecules-25-05768"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maridass</surname><given-names>M.</given-names></name><name><surname>De Britto</surname><given-names>A.J.</given-names></name></person-group><article-title>Origins of plant derived medicines</article-title><source>Ethnobot. Leafl.</source><year>2008</year><volume>12</volume><fpage>373</fpage><lpage>387</lpage></element-citation></ref><ref id="B5-molecules-25-05768"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabassum</surname><given-names>N.</given-names></name><name><surname>Ahmad</surname><given-names>F.</given-names></name></person-group><article-title>Role of natural herbs in the treatment of hypertension</article-title><source>Pharmacogn. Rev.</source><year>2011</year><volume>5</volume><fpage>30</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.4103/0973-7847.79097</pub-id><pub-id pub-id-type="pmid">22096316</pub-id></element-citation></ref><ref id="B6-molecules-25-05768"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>T.</given-names></name><name><surname>Ali</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Nisar</surname><given-names>P.</given-names></name><name><surname>Jan</surname><given-names>S.A.</given-names></name><name><surname>Afridi</surname><given-names>S.</given-names></name><name><surname>Shinwari</surname><given-names>Z.K.</given-names></name></person-group><article-title>Anticancer Plants: A Review of the Active Phytochemicals, Applications in Animal Models, and Regulatory Aspects</article-title><source>Biomolecules</source><year>2019</year><volume>10</volume><elocation-id>47</elocation-id><pub-id pub-id-type="doi">10.3390/biom10010047</pub-id></element-citation></ref><ref id="B7-molecules-25-05768"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chand</surname><given-names>S.</given-names></name><name><surname>Dave</surname><given-names>R.</given-names></name></person-group><article-title>In Vitro models for antioxidant activity evaluation and some medicinal plants possessing antioxidant properties: An overview</article-title><source>Afr. J. Microbiol. Res.</source><year>2009</year><volume>3</volume><fpage>981</fpage><lpage>996</lpage></element-citation></ref><ref id="B8-molecules-25-05768"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duthie</surname><given-names>G.G.</given-names></name><name><surname>Duthie</surname><given-names>S.J.</given-names></name><name><surname>Kyle</surname><given-names>J.A.</given-names></name></person-group><article-title>Plant polyphenols in cancer and heart disease: Implications as nutritional antioxidants</article-title><source>Nutr. Res. Rev.</source><year>2000</year><volume>13</volume><fpage>79</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1079/095442200108729016</pub-id><pub-id pub-id-type="pmid">19087434</pub-id></element-citation></ref><ref id="B9-molecules-25-05768"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blokhina</surname><given-names>O.</given-names></name><name><surname>Virolainen</surname><given-names>E.</given-names></name><name><surname>Fagerstedt</surname><given-names>K.V.</given-names></name></person-group><article-title>Antioxidants, oxidative damage and oxygen deprivation stress: A review</article-title><source>Ann. Bot.</source><year>2003</year><volume>91</volume><fpage>179</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1093/aob/mcf118</pub-id><pub-id pub-id-type="pmid">12509339</pub-id></element-citation></ref><ref id="B10-molecules-25-05768"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>H.</given-names></name><name><surname>Dudareva</surname><given-names>N.</given-names></name></person-group><article-title>The shikimate pathway and aromatic amino Acid biosynthesis in plants</article-title><source>Annu. Rev. Plant Biol.</source><year>2012</year><volume>63</volume><fpage>73</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1146/annurev-arplant-042811-105439</pub-id><pub-id pub-id-type="pmid">22554242</pub-id></element-citation></ref><ref id="B11-molecules-25-05768"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollace</surname><given-names>V.</given-names></name><name><surname>Scicchitano</surname><given-names>M.</given-names></name><name><surname>Paone</surname><given-names>S.</given-names></name><name><surname>Casale</surname><given-names>F.</given-names></name><name><surname>Calandruccio</surname><given-names>C.</given-names></name><name><surname>Gliozzi</surname><given-names>M.</given-names></name><name><surname>Musolino</surname><given-names>V.</given-names></name><name><surname>Carresi</surname><given-names>C.</given-names></name><name><surname>Maiuolo</surname><given-names>J.</given-names></name><name><surname>Nucera</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Hypoglycemic and Hypolipemic Effects of a New Lecithin Formulation of Bergamot Polyphenolic Fraction: A Double Blind, Randomized, Placebo-Controlled Study</article-title><source>Endocr. Metab. Immune Disord. Drug Targets</source><year>2019</year><volume>19</volume><fpage>136</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.2174/1871530319666181203151513</pub-id><?supplied-pmid 30501605?><pub-id pub-id-type="pmid">30501605</pub-id></element-citation></ref><ref id="B12-molecules-25-05768"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musolino</surname><given-names>V.</given-names></name><name><surname>Gliozzi</surname><given-names>M.</given-names></name><name><surname>Nucera</surname><given-names>S.</given-names></name><name><surname>Carresi</surname><given-names>C.</given-names></name><name><surname>Maiuolo</surname><given-names>J.</given-names></name><name><surname>Mollace</surname><given-names>R.</given-names></name><name><surname>Paone</surname><given-names>S.</given-names></name><name><surname>Bosco</surname><given-names>F.</given-names></name><name><surname>Scarano</surname><given-names>F.</given-names></name><name><surname>Scicchitano</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The effect of bergamot polyphenolic fraction on lipid transfer protein system and vascular oxidative stress in a rat model of hyperlipemia</article-title><source>Lipids Health Dis.</source><year>2019</year><volume>18</volume><fpage>115</fpage><pub-id pub-id-type="doi">10.1186/s12944-019-1061-0</pub-id><?supplied-pmid 31101130?><pub-id pub-id-type="pmid">31101130</pub-id></element-citation></ref><ref id="B13-molecules-25-05768"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musolino</surname><given-names>V.</given-names></name><name><surname>Gliozzi</surname><given-names>M.</given-names></name><name><surname>Bombardelli</surname><given-names>E.</given-names></name><name><surname>Nucera</surname><given-names>S.</given-names></name><name><surname>Carresi</surname><given-names>C.</given-names></name><name><surname>Maiuolo</surname><given-names>J.</given-names></name><name><surname>Mollace</surname><given-names>R.</given-names></name><name><surname>Paone</surname><given-names>S.</given-names></name><name><surname>Bosco</surname><given-names>F.</given-names></name><name><surname>Scarano</surname><given-names>F.</given-names></name><etal/></person-group><article-title>The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease</article-title><source>J. Tradit. Complement. Med.</source><year>2020</year><volume>10</volume><fpage>268</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/j.jtcme.2020.02.004</pub-id><?supplied-pmid 32670822?><pub-id pub-id-type="pmid">32670822</pub-id></element-citation></ref><ref id="B14-molecules-25-05768"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oppedisano</surname><given-names>F.</given-names></name><name><surname>Muscoli</surname><given-names>C.</given-names></name><name><surname>Musolino</surname><given-names>V.</given-names></name><name><surname>Carresi</surname><given-names>C.</given-names></name><name><surname>Macr&#x000ec;</surname><given-names>R.</given-names></name><name><surname>Giancotta</surname><given-names>C.</given-names></name><name><surname>Bosco</surname><given-names>F.</given-names></name><name><surname>Maiuolo</surname><given-names>J.</given-names></name><name><surname>Scarano</surname><given-names>F.</given-names></name><name><surname>Paone</surname><given-names>S.</given-names></name><etal/></person-group><article-title>The Protective Effect of Cynara Cardunculus Extract in Diet-Induced NAFLD: Involvement of OCTN1 and OCTN2 Transporter Subfamily</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1435</elocation-id><pub-id pub-id-type="doi">10.3390/nu12051435</pub-id><?supplied-pmid 32429274?><pub-id pub-id-type="pmid">32429274</pub-id></element-citation></ref><ref id="B15-molecules-25-05768"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Burgos</surname><given-names>E.</given-names></name><name><surname>G&#x000f3;mez-Serranillos</surname><given-names>M.P.</given-names></name></person-group><article-title>Terpene compounds in nature: A review of their potential antioxidantactivity</article-title><source>Curr. Med. Chem.</source><year>2012</year><volume>19</volume><fpage>5319</fpage><lpage>5341</lpage><pub-id pub-id-type="doi">10.2174/092986712803833335</pub-id><?supplied-pmid 22963623?><pub-id pub-id-type="pmid">22963623</pub-id></element-citation></ref><ref id="B16-molecules-25-05768"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chadwick</surname><given-names>M.</given-names></name><name><surname>Trewin</surname><given-names>H.</given-names></name><name><surname>Gawthrop</surname><given-names>F.</given-names></name><name><surname>Wagstaff</surname><given-names>C.</given-names></name></person-group><article-title>Sesquiterpenoids Lactones: Benefits to Plants and People</article-title><source>Int. J. Mol. Sci.</source><year>2013</year><volume>14</volume><fpage>12780</fpage><lpage>12805</lpage><pub-id pub-id-type="doi">10.3390/ijms140612780</pub-id><pub-id pub-id-type="pmid">23783276</pub-id></element-citation></ref><ref id="B17-molecules-25-05768"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeena</surname><given-names>K.</given-names></name><name><surname>Liju</surname><given-names>V.B.</given-names></name><name><surname>Kuttan</surname><given-names>R.</given-names></name></person-group><article-title>A preliminary 13-week oral toxicity study of ginger oil in male and female Wistar rats</article-title><source>Int. J. Toxicol.</source><year>2011</year><volume>30</volume><fpage>662</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1177/1091581811419023</pub-id><pub-id pub-id-type="pmid">21960667</pub-id></element-citation></ref><ref id="B18-molecules-25-05768"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghareeb</surname><given-names>D.A.</given-names></name><name><surname>ElAhwany</surname><given-names>A.M.D.</given-names></name><name><surname>El-mallawany</surname><given-names>S.M.</given-names></name><name><surname>Saif</surname><given-names>A.A.</given-names></name></person-group><article-title>In vitro screening for anti-acetylcholiesterase, anti-oxidant, anti-glucosidase, anti-inflammatory and anti-bacterial effect of three traditional medicinal plants</article-title><source>Biotechnol. Biotechnol. Equip.</source><year>2014</year><volume>28</volume><fpage>1155</fpage><lpage>1164</lpage><pub-id pub-id-type="doi">10.1080/13102818.2014.969877</pub-id><pub-id pub-id-type="pmid">26740784</pub-id></element-citation></ref><ref id="B19-molecules-25-05768"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishnava</surname><given-names>J.B.</given-names></name><name><surname>Chauhan</surname><given-names>M.B.</given-names></name></person-group><article-title>Anticariogenic and phytochemical evaluation of Eucalyptus globules Labill</article-title><source>Saudi J. Biol. Sci.</source><year>2013</year><volume>20</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.sjbs.2012.11.003</pub-id><pub-id pub-id-type="pmid">23961222</pub-id></element-citation></ref><ref id="B20-molecules-25-05768"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li-Weber</surname><given-names>M.</given-names></name><name><surname>Giaisi</surname><given-names>M.</given-names></name><name><surname>Treibe</surname><given-names>M.K.</given-names></name><name><surname>Krammer</surname><given-names>P.H.</given-names></name></person-group><article-title>The anti-inflammatory sesquiterpene lactone parthenolide suppresses IL-4 gene expression in peripheral blood T</article-title><source>Eur. J. Immunol.</source><year>2002</year><volume>32</volume><fpage>3587</fpage><lpage>3597</lpage><pub-id pub-id-type="doi">10.1002/1521-4141(200212)32:12&#x0003c;3587::AID-IMMU3587&#x0003e;3.0.CO;2-E</pub-id><pub-id pub-id-type="pmid">12516545</pub-id></element-citation></ref><ref id="B21-molecules-25-05768"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramov</surname><given-names>A.Y.</given-names></name><name><surname>Zamaraeva</surname><given-names>M.V.</given-names></name><name><surname>Hagelgans</surname><given-names>A.I.</given-names></name><name><surname>Azimov</surname><given-names>R.R.</given-names></name><name><surname>Krasilnikov</surname><given-names>O.V.</given-names></name></person-group><article-title>Influence of plant terpenoids on the permeability of mitochondria and lipid bilayers</article-title><source>Biochim. Biophys. Acta</source><year>2001</year><volume>1512</volume><fpage>98</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/S0005-2736(01)00307-8</pub-id><pub-id pub-id-type="pmid">11334628</pub-id></element-citation></ref><ref id="B22-molecules-25-05768"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>M.J.</given-names></name><name><surname>Bootman</surname><given-names>M.D.</given-names></name><name><surname>Roderick</surname><given-names>H.L.</given-names></name></person-group><article-title>Calcium signalling: Dynamics, homeostasis and remodelling</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2003</year><volume>4</volume><fpage>517</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1038/nrm1155</pub-id><?supplied-pmid 12838335?><pub-id pub-id-type="pmid">12838335</pub-id></element-citation></ref><ref id="B23-molecules-25-05768"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gliozzi</surname><given-names>M.</given-names></name><name><surname>Scarano</surname><given-names>F.</given-names></name><name><surname>Musolino</surname><given-names>V.</given-names></name><name><surname>Carresi</surname><given-names>C.</given-names></name><name><surname>Scicchitano</surname><given-names>M.</given-names></name><name><surname>Ruga</surname><given-names>S.</given-names></name><name><surname>Zito</surname><given-names>M.C.</given-names></name><name><surname>Nucera</surname><given-names>S.</given-names></name><name><surname>Bosco</surname><given-names>F.</given-names></name><name><surname>Maiuolo</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Role of TSPO/VDAC1 Upregulation and Matrix Metalloproteinase-2 Localization in the Dysfunctional Myocardium of Hyperglycaemic Rats</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>7432</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21207432</pub-id><?supplied-pmid 33050121?><pub-id pub-id-type="pmid">33050121</pub-id></element-citation></ref><ref id="B24-molecules-25-05768"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Xin</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Qu</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name></person-group><article-title>Recent Advances on Bioactive Constituents in Ferula</article-title><source>Drug Dev. Res.</source><year>2017</year><volume>78</volume><fpage>321</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1002/ddr.21402</pub-id><pub-id pub-id-type="pmid">28786182</pub-id></element-citation></ref><ref id="B25-molecules-25-05768"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Conti</surname><given-names>F.</given-names></name><name><surname>Abbate</surname><given-names>G.</given-names></name><name><surname>Alessandrini</surname><given-names>A.</given-names></name><name><surname>Blasi</surname><given-names>C.</given-names></name></person-group><source>An Annotated Checklist of the Italian Vascular Flora</source><publisher-name>Palombi Editori</publisher-name><publisher-loc>Roma, Italy</publisher-loc><year>2005</year></element-citation></ref><ref id="B26-molecules-25-05768"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akaberi</surname><given-names>M.</given-names></name><name><surname>Iranshahy</surname><given-names>M.</given-names></name><name><surname>Iranshahi</surname><given-names>M.</given-names></name></person-group><article-title>Review of the traditional uses, phytochemistry, pharmacology and toxicology of giant fennel (<italic>Ferula communis</italic> L. subsp. communis)</article-title><source>Iran J. Basic Med. Sci.</source><year>2015</year><volume>18</volume><fpage>1050</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">26949491</pub-id></element-citation></ref><ref id="B27-molecules-25-05768"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gault</surname><given-names>G.</given-names></name><name><surname>Lefebvre</surname><given-names>S.</given-names></name><name><surname>Benoit</surname><given-names>E.</given-names></name><name><surname>Lattard</surname><given-names>V.</given-names></name><name><surname>Grancher</surname><given-names>D.</given-names></name></person-group><article-title>Variability of ferulenol and ferprenin concentration in French giant fennel (<italic>Ferula</italic> sp.) leaves</article-title><source>Toxicon</source><year>2019</year><volume>165</volume><fpage>47</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2019.04.010</pub-id><pub-id pub-id-type="pmid">31034847</pub-id></element-citation></ref><ref id="B28-molecules-25-05768"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergman</surname><given-names>M.E.</given-names></name><name><surname>Davis</surname><given-names>B.</given-names></name><name><surname>Phillips</surname><given-names>M.A.</given-names></name></person-group><article-title>Medically Useful Plant Terpenoids: Biosynthesis, Occurrence, and Mechanism of Action</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>3961</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24213961</pub-id></element-citation></ref><ref id="B29-molecules-25-05768"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubiolo</surname><given-names>P.</given-names></name><name><surname>Matteodo</surname><given-names>M.</given-names></name><name><surname>Riccio</surname><given-names>G.</given-names></name><name><surname>Ballero</surname><given-names>M.</given-names></name><name><surname>Christen</surname><given-names>P.</given-names></name><name><surname>Fleury-Souverain</surname><given-names>S.</given-names></name><name><surname>Veuthey</surname><given-names>J.L.</given-names></name><name><surname>Bicchi</surname><given-names>C.</given-names></name></person-group><article-title>Analytical discrimination of poisonous and nonpoisonous chemotypes of giant fennel (<italic>Ferula communis</italic> L.) through their biologically active and volatile fractions</article-title><source>J. Agric. Food Chem.</source><year>2006</year><volume>54</volume><fpage>7556</fpage><lpage>7563</lpage><pub-id pub-id-type="doi">10.1021/jf061592t</pub-id><pub-id pub-id-type="pmid">17002421</pub-id></element-citation></ref><ref id="B30-molecules-25-05768"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miski</surname><given-names>M.</given-names></name><name><surname>Mabry</surname><given-names>T.J.</given-names></name></person-group><article-title>Daucane esters from <italic>Ferula communis</italic> subsp. communis</article-title><source>Phytochemistry</source><year>1985</year><volume>24</volume><fpage>1735</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)82543-1</pub-id></element-citation></ref><ref id="B31-molecules-25-05768"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazari</surname><given-names>Z.E.</given-names></name><name><surname>Iranshahi</surname><given-names>M.</given-names></name></person-group><article-title>Biologically active sesquiterpene coumarins from Ferula species</article-title><source>Phytother Res</source><year>2011</year><volume>25</volume><fpage>315</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1002/ptr.3311</pub-id><pub-id pub-id-type="pmid">21031633</pub-id></element-citation></ref><ref id="B32-molecules-25-05768"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iranshahi</surname><given-names>M.</given-names></name><name><surname>Rezaee</surname><given-names>R.</given-names></name><name><surname>Najaf Najafi</surname><given-names>M.</given-names></name><name><surname>Haghbin</surname><given-names>A.</given-names></name><name><surname>Kasaian</surname><given-names>J.</given-names></name></person-group><article-title>Cytotoxic activity of the genus Ferula (Apiaceae) and its bioactive constituents</article-title><source>Avicenna J. Phytomed.</source><year>2018</year><volume>8</volume><fpage>296</fpage><lpage>312</lpage><?supplied-pmid 30377589?><pub-id pub-id-type="pmid">30377589</pub-id></element-citation></ref><ref id="B33-molecules-25-05768"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appendino</surname><given-names>G.</given-names></name><name><surname>Spagliardi</surname><given-names>P.</given-names></name><name><surname>Cravotto</surname><given-names>G.</given-names></name><name><surname>Pocock</surname><given-names>V.</given-names></name><name><surname>Milligan</surname><given-names>S.</given-names></name></person-group><article-title>Daucane phytoestrogens: A structure-activity study</article-title><source>J. Nat. Prod.</source><year>2002</year><volume>65</volume><fpage>1612</fpage><lpage>1615</lpage><pub-id pub-id-type="doi">10.1021/np0201671</pub-id><?supplied-pmid 12444685?><pub-id pub-id-type="pmid">12444685</pub-id></element-citation></ref><ref id="B34-molecules-25-05768"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sattar</surname><given-names>Z.</given-names></name><name><surname>Iranshahi</surname><given-names>M.</given-names></name></person-group><article-title>Phytochemistry and Pharmacology of Ferula hermonis Boiss.&#x02014;A Review</article-title><source>Drug Res. (Stuttg.)</source><year>2017</year><volume>67</volume><fpage>437</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1055/s-0043-109100</pub-id><?supplied-pmid 28521374?><pub-id pub-id-type="pmid">28521374</pub-id></element-citation></ref><ref id="B35-molecules-25-05768"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macho</surname><given-names>A.</given-names></name><name><surname>Blanco-Molina</surname><given-names>M.</given-names></name><name><surname>Spagliardi</surname><given-names>P.</given-names></name><name><surname>Appendino</surname><given-names>G.</given-names></name><name><surname>Bremner</surname><given-names>P.</given-names></name><name><surname>Heinrich</surname><given-names>M.</given-names></name><name><surname>Fiebich</surname><given-names>B.L.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>E.</given-names></name></person-group><article-title>Calcium ionophoretic and apoptotic effects of ferutinin in the human Jurkat T-cell line</article-title><source>Biochem. Pharm.</source><year>2004</year><volume>68</volume><fpage>875</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2004.05.016</pub-id><?supplied-pmid 15294450?><pub-id pub-id-type="pmid">15294450</pub-id></element-citation></ref><ref id="B36-molecules-25-05768"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matin</surname><given-names>M.M.</given-names></name><name><surname>Nakhaeizadeh</surname><given-names>H.</given-names></name><name><surname>Bahrami</surname><given-names>A.R.</given-names></name><name><surname>Iranshahi</surname><given-names>M.</given-names></name><name><surname>Arghiani</surname><given-names>N.</given-names></name><name><surname>Rassouli</surname><given-names>F.B.</given-names></name></person-group><article-title>Ferutinin, an apoptosis inducing terpenoid from Ferula ovina</article-title><source>Asian Pac. J. Cancer Prev.</source><year>2014</year><volume>15</volume><fpage>2123</fpage><lpage>2128</lpage><pub-id pub-id-type="doi">10.7314/APJCP.2014.15.5.2123</pub-id><?supplied-pmid 24716944?><pub-id pub-id-type="pmid">24716944</pub-id></element-citation></ref><ref id="B37-molecules-25-05768"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Ja&#x02019;fari</surname><given-names>A.H.</given-names></name><name><surname>Vila</surname><given-names>R.</given-names></name><name><surname>Freixa</surname><given-names>B.</given-names></name><name><surname>Costa</surname><given-names>J.</given-names></name><name><surname>Ca&#x000f1;igueral</surname><given-names>S.</given-names></name></person-group><article-title>Antifungal compounds from the rhizome and roots of Ferula hermonis</article-title><source>Phytother. Res.</source><year>2013</year><volume>27</volume><fpage>911</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1002/ptr.4806</pub-id><?supplied-pmid 22927102?><pub-id pub-id-type="pmid">22927102</pub-id></element-citation></ref><ref id="B38-molecules-25-05768"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamoci</surname><given-names>E.</given-names></name><name><surname>Cavoski</surname><given-names>I.</given-names></name><name><surname>Simeone</surname><given-names>V.</given-names></name><name><surname>Mondelli</surname><given-names>D.</given-names></name><name><surname>Al-Bitar</surname><given-names>L.</given-names></name><name><surname>Caboni</surname><given-names>P.</given-names></name></person-group><article-title>Chemical composition and in vitro activity of plant extracts from Ferula communis and Dittrichia viscosa against postharvest fungi</article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>2609</fpage><lpage>2625</lpage><pub-id pub-id-type="doi">10.3390/molecules16032609</pub-id><pub-id pub-id-type="pmid">21441864</pub-id></element-citation></ref><ref id="B39-molecules-25-05768"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abourashed</surname><given-names>E.A.</given-names></name><name><surname>Galal</surname><given-names>A.M.</given-names></name><name><surname>Shibl</surname><given-names>A.M.</given-names></name></person-group><article-title>Antimycobacterial activity of ferutinin alone and in combination with antitubercular drugs against a rapidly growing surrogate of Mycobacterium tuberculosis</article-title><source>Nat. Prod. Res.</source><year>2001</year><volume>25</volume><fpage>1142</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1080/14786419.2010.481623</pub-id></element-citation></ref><ref id="B40-molecules-25-05768"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiokias</surname><given-names>S.</given-names></name><name><surname>Proestos</surname><given-names>C.</given-names></name><name><surname>Oreopoulou</surname><given-names>V.</given-names></name></person-group><article-title>Phenolic Acids of Plant Origin&#x02014;A Review on Their Antioxidant Activity In Vitro (O/W Emulsion Systems) Along with Their in Vivo Health Biochemical Properties</article-title><source>Foods</source><year>2020</year><volume>9</volume><elocation-id>534</elocation-id><pub-id pub-id-type="doi">10.3390/foods9040534</pub-id></element-citation></ref><ref id="B41-molecules-25-05768"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ornano</surname><given-names>L.</given-names></name><name><surname>Venditti</surname><given-names>A.</given-names></name><name><surname>Ballero</surname><given-names>M.</given-names></name><name><surname>Sanna</surname><given-names>C.</given-names></name><name><surname>Quassinti</surname><given-names>L.</given-names></name><name><surname>Bramucci</surname><given-names>M.</given-names></name><name><surname>Lupidi</surname><given-names>G.</given-names></name><name><surname>Papa</surname><given-names>F.</given-names></name><name><surname>Vittori</surname><given-names>S.</given-names></name><name><surname>Maggi</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Chemopreventive and antioxidant activity of the chamazulene-richessential oil obtained from Artemisia arborescens L. growing on the Isle of La Maddalena, Sardinia, Italy</article-title><source>Chem. Biodivers.</source><year>2013</year><volume>10</volume><fpage>1464</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.1002/cbdv.201200435</pub-id><pub-id pub-id-type="pmid">23939794</pub-id></element-citation></ref><ref id="B42-molecules-25-05768"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geroushi</surname><given-names>A.</given-names></name><name><surname>Auzi</surname><given-names>A.A.</given-names></name><name><surname>Elhwuegi</surname><given-names>A.S.</given-names></name><name><surname>Elzawam</surname><given-names>F.</given-names></name><name><surname>Elsherif</surname><given-names>A.</given-names></name><name><surname>Nahar</surname><given-names>L.</given-names></name><name><surname>Sarker</surname><given-names>S.D.</given-names></name></person-group><article-title>Antiinflammatory sesquiterpenes from the root oil of Ferula hermonis</article-title><source>Phytother. Res.</source><year>2011</year><volume>25</volume><fpage>774</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1002/ptr.3324</pub-id><pub-id pub-id-type="pmid">21520471</pub-id></element-citation></ref><ref id="B43-molecules-25-05768"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raafat</surname><given-names>K.M.</given-names></name></person-group><article-title>Exploration of the Protective Effects of Some Natural Compounds against Neurodegeneration Exploiting Glycine Receptors in vivo Model</article-title><source>Nat. Prod. Chem. Res.</source><year>2013</year><volume>1</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.4172/2329-6836.1000113</pub-id></element-citation></ref><ref id="B44-molecules-25-05768"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sepici-Dincel</surname><given-names>A.</given-names></name><name><surname>Acikgoz</surname><given-names>S.</given-names></name><name><surname>Cevik</surname><given-names>C.</given-names></name><name><surname>Sengelen</surname><given-names>M.</given-names></name><name><surname>Yesilada</surname><given-names>E.</given-names></name></person-group><article-title>Effects of in vivo antioxidant enzyme activities of myrtle oil in normoglycaemic and alloxan diabetic rabbits</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>110</volume><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.10.015</pub-id><?supplied-pmid 17101252?><pub-id pub-id-type="pmid">17101252</pub-id></element-citation></ref><ref id="B45-molecules-25-05768"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raafat</surname><given-names>K.</given-names></name><name><surname>El-Lakani</surname><given-names>A.</given-names></name></person-group><article-title>Acute and subchronic in-vivo effects of <italic>Ferula hermonis</italic> L. and <italic>Sambucus nigra</italic> L. and their potential active isolates in a diabetic mouse model of neuropathic pain</article-title><source>BMC Complement. Altern. Med.</source><year>2015</year><volume>15</volume><elocation-id>257</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-015-0780-7</pub-id><?supplied-pmid 26220172?><pub-id pub-id-type="pmid">26220172</pub-id></element-citation></ref><ref id="B46-molecules-25-05768"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marjoribanks</surname><given-names>J.</given-names></name><name><surname>Farquhar</surname><given-names>C.</given-names></name><name><surname>Roberts</surname><given-names>H.</given-names></name><name><surname>Lethaby</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group><article-title>Long-term hormone therapy for perimenopausal and postmenopausal women</article-title><source>Cochrane Database Syst. Rev.</source><year>2017</year><volume>1</volume><fpage>CD004143</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD004143.pub5</pub-id><?supplied-pmid 28093732?><pub-id pub-id-type="pmid">28093732</pub-id></element-citation></ref><ref id="B47-molecules-25-05768"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiosano</surname><given-names>D.</given-names></name><name><surname>Paris</surname><given-names>F.</given-names></name><name><surname>Grimaldi</surname><given-names>M.</given-names></name><name><surname>Georgescu</surname><given-names>V.</given-names></name><name><surname>Servant</surname><given-names>N.</given-names></name><name><surname>Hochberg</surname><given-names>Z.</given-names></name><name><surname>Balaguer</surname><given-names>P.</given-names></name><name><surname>Sultan</surname><given-names>C.</given-names></name></person-group><article-title>Evidence of ERalpha and ERbeta selectivity and partial estrogen agonism in traditional Chinese medicine</article-title><source>Reprod. Biol. Endocrinol.</source><year>2014</year><volume>12</volume><fpage>97</fpage><pub-id pub-id-type="doi">10.1186/1477-7827-12-97</pub-id><pub-id pub-id-type="pmid">25300391</pub-id></element-citation></ref><ref id="B48-molecules-25-05768"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferretti</surname><given-names>M.</given-names></name><name><surname>Bertoni</surname><given-names>L.</given-names></name><name><surname>Cavani</surname><given-names>F.</given-names></name><name><surname>Benincasa</surname><given-names>M.</given-names></name><name><surname>Sena</surname><given-names>P.</given-names></name><name><surname>Carnevale</surname><given-names>G.</given-names></name><name><surname>Zavatti</surname><given-names>M.</given-names></name><name><surname>Di Viesti</surname><given-names>V.</given-names></name><name><surname>Zanoli</surname><given-names>P.</given-names></name><name><surname>Palumbo</surname><given-names>C.</given-names></name></person-group><article-title>Structural and histomorphometric evaluations of ferutinin effects on the uterus of ovariectomized rats during osteoporosis treatment</article-title><source>Life Sci.</source><year>2012</year><volume>90</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2011.11.001</pub-id><pub-id pub-id-type="pmid">22100510</pub-id></element-citation></ref><ref id="B49-molecules-25-05768"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oseni</surname><given-names>T.</given-names></name><name><surname>Patel</surname><given-names>R.</given-names></name><name><surname>Pyle</surname><given-names>J.</given-names></name><name><surname>Jordan</surname><given-names>V.C.</given-names></name></person-group><article-title>Selective estrogen receptor modulators and phytoestrogens</article-title><source>Planta Med.</source><year>2008</year><volume>74</volume><fpage>1656</fpage><lpage>1665</lpage><pub-id pub-id-type="doi">10.1055/s-0028-1088304</pub-id><pub-id pub-id-type="pmid">18843590</pub-id></element-citation></ref><ref id="B50-molecules-25-05768"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paterni</surname><given-names>I.</given-names></name><name><surname>Granchi</surname><given-names>C.</given-names></name><name><surname>Katzenellenbogen</surname><given-names>J.A.</given-names></name><name><surname>Minutolo</surname><given-names>F.</given-names></name></person-group><article-title>Estrogen Receptors Alpha (ER&#x003b1;) and Beta (ER&#x003b2;): Subtype-Selective Ligands and Clinical Potential</article-title><source>Steroids</source><year>2014</year><volume>90</volume><fpage>13</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.steroids.2014.06.012</pub-id><pub-id pub-id-type="pmid">24971815</pub-id></element-citation></ref><ref id="B51-molecules-25-05768"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Horie-Inoue</surname><given-names>K.</given-names></name><name><surname>Inoue</surname><given-names>S.</given-names></name></person-group><article-title>Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology</article-title><source>Acta Pharmacol. Sin.</source><year>2015</year><volume>36</volume><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1038/aps.2014.123</pub-id><pub-id pub-id-type="pmid">25500870</pub-id></element-citation></ref><ref id="B52-molecules-25-05768"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prossnitz</surname><given-names>E.R.</given-names></name><name><surname>Arterburn</surname><given-names>J.B.</given-names></name></person-group><article-title>International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators</article-title><source>Pharmacol. Rev.</source><year>2015</year><volume>67</volume><fpage>505</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1124/pr.114.009712</pub-id><pub-id pub-id-type="pmid">26023144</pub-id></element-citation></ref><ref id="B53-molecules-25-05768"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanoli</surname><given-names>P.</given-names></name><name><surname>Zavatti</surname><given-names>M.</given-names></name><name><surname>Geminiani</surname><given-names>E.</given-names></name><name><surname>Corsi</surname><given-names>L.</given-names></name><name><surname>Baraldi</surname><given-names>M.</given-names></name></person-group><article-title>The phytoestrogen ferutinin affects female sexual behavior modulating ERalpha expression in the hypothalamus</article-title><source>Behav. Brain Res.</source><year>2009</year><volume>199</volume><fpage>283</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2008.12.009</pub-id><pub-id pub-id-type="pmid">19124045</pub-id></element-citation></ref><ref id="B54-molecules-25-05768"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>M.</given-names></name><name><surname>McCaskill-Stevens</surname><given-names>W.</given-names></name><name><surname>Lampe</surname><given-names>J.W.</given-names></name></person-group><article-title>Addressing the soy and breast cancer relationship: Review, commentary, and workshop proceedings</article-title><source>J. Natl. Cancer Inst.</source><year>2006</year><volume>98</volume><fpage>1275</fpage><lpage>1284</lpage><pub-id pub-id-type="doi">10.1093/jnci/djj356</pub-id><?supplied-pmid 16985246?><pub-id pub-id-type="pmid">16985246</pub-id></element-citation></ref><ref id="B55-molecules-25-05768"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavani</surname><given-names>F.</given-names></name><name><surname>Ferretti</surname><given-names>M.</given-names></name><name><surname>Carnevale</surname><given-names>G.</given-names></name><name><surname>Bertoni</surname><given-names>L.</given-names></name><name><surname>Zavatti</surname><given-names>M.</given-names></name><name><surname>Palumbo</surname><given-names>C.</given-names></name></person-group><article-title>Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats</article-title><source>J. Bone Miner. Metab.</source><year>2012</year><volume>30</volume><fpage>619</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1007/s00774-012-0366-0</pub-id><?supplied-pmid 22828874?><pub-id pub-id-type="pmid">22828874</pub-id></element-citation></ref><ref id="B56-molecules-25-05768"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palumbo</surname><given-names>C.</given-names></name><name><surname>Ferretti</surname><given-names>M.</given-names></name><name><surname>Bertoni</surname><given-names>L.</given-names></name><name><surname>Cavani</surname><given-names>F.</given-names></name><name><surname>Resca</surname><given-names>E.</given-names></name><name><surname>Casolari</surname><given-names>B.</given-names></name><name><surname>Carnevale</surname><given-names>G.</given-names></name><name><surname>Zavatti</surname><given-names>M.</given-names></name><name><surname>Montanari</surname><given-names>C.</given-names></name><name><surname>Benelli</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Influence of ferutinin on bone metabolism in ovariectomized rats. I: Role in preventing osteoporosis</article-title><source>J. Bone Miner. Metab.</source><year>2009</year><volume>27</volume><fpage>538</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1007/s00774-009-0070-x</pub-id><?supplied-pmid 19333679?><pub-id pub-id-type="pmid">19333679</pub-id></element-citation></ref><ref id="B57-molecules-25-05768"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferretti</surname><given-names>M.</given-names></name><name><surname>Bertoni</surname><given-names>L.</given-names></name><name><surname>Cavani</surname><given-names>F.</given-names></name><name><surname>Zavatti</surname><given-names>M.</given-names></name><name><surname>Resca</surname><given-names>E.</given-names></name><name><surname>Carnevale</surname><given-names>G.</given-names></name><name><surname>Benelli</surname><given-names>A.</given-names></name><name><surname>Zanoli</surname><given-names>P.</given-names></name><name><surname>Palumbo</surname><given-names>C.</given-names></name></person-group><article-title>Influence of ferutinin on bone metabolism in ovariectomized rats. II: Role in recovering osteoporosis</article-title><source>J. Anat.</source><year>2010</year><volume>217</volume><fpage>48</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7580.2010.01242.x</pub-id><?supplied-pmid 20492429?><pub-id pub-id-type="pmid">20492429</pub-id></element-citation></ref><ref id="B58-molecules-25-05768"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolph</surname><given-names>D.N.</given-names></name><name><surname>Deb</surname><given-names>M.</given-names></name><name><surname>Kanji</surname><given-names>S.</given-names></name><name><surname>Greene</surname><given-names>C.J.</given-names></name><name><surname>Das</surname><given-names>M.</given-names></name><name><surname>Joseph</surname><given-names>M.</given-names></name><name><surname>Aggarwal</surname><given-names>R.</given-names></name><name><surname>Leblebicioglu</surname><given-names>B.</given-names></name><name><surname>Das</surname><given-names>H.</given-names></name></person-group><article-title>Ferutinin directs dental pulp-derived stem cells towards the osteogenic lineage by epigenetically regulating canonical Wnt signalling</article-title><source>Biochim. Biophys. Acta Mol. Basis Dis.</source><year>2018</year><volume>S0925-4439</volume><fpage>30435</fpage><lpage>30436</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2018.10.032</pub-id></element-citation></ref><ref id="B59-molecules-25-05768"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamaraeva</surname><given-names>M.</given-names></name><name><surname>Charishnikova</surname><given-names>O.</given-names></name><name><surname>Saidkhodjaev</surname><given-names>A.</given-names></name><name><surname>Isidorov</surname><given-names>V.</given-names></name><name><surname>Granosik</surname><given-names>M.</given-names></name><name><surname>R&#x000f3;&#x0017c;alski</surname><given-names>M.</given-names></name><name><surname>Wata&#x00142;a</surname><given-names>C.</given-names></name></person-group><article-title>Calcium mobilization by the plant estrogen ferutinin does not induce blood platelet aggregation</article-title><source>Pharmacol. Rep.</source><year>2010</year><volume>62</volume><fpage>1117</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1016/S1734-1140(10)70374-1</pub-id><pub-id pub-id-type="pmid">21273669</pub-id></element-citation></ref><ref id="B60-molecules-25-05768"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilyich</surname><given-names>T.</given-names></name><name><surname>Charishnikova</surname><given-names>O.</given-names></name><name><surname>Sekowski</surname><given-names>S.</given-names></name><name><surname>Zamaraeva</surname><given-names>M.</given-names></name><name><surname>Cheshchevik</surname><given-names>V.</given-names></name><name><surname>Dremza</surname><given-names>I.</given-names></name><name><surname>Cheshchevik</surname><given-names>N.</given-names></name><name><surname>Kiryukhina</surname><given-names>L.</given-names></name><name><surname>Lapshina</surname><given-names>E.</given-names></name><name><surname>Zavodnik</surname><given-names>I.</given-names></name></person-group><article-title>Ferutinin Induces Membrane Depolarization, Permeability Transition Pore Formation, and Respiration Uncoupling in Isolated Rat Liver Mitochondria by Stimulation of Ca<sub>2+</sub>-Permeability</article-title><source>J. Membr. Biol.</source><year>2018</year><volume>251</volume><fpage>563</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1007/s00232-018-0032-0</pub-id><?supplied-pmid 29594529?><pub-id pub-id-type="pmid">29594529</pub-id></element-citation></ref><ref id="B61-molecules-25-05768"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nealen</surname><given-names>M.L.</given-names></name><name><surname>Vijayan</surname><given-names>K.V.</given-names></name><name><surname>Bolton</surname><given-names>E.</given-names></name><name><surname>Bray</surname><given-names>P.F.</given-names></name></person-group><article-title>Human platelets contain a glycosylated estrogen receptor</article-title><source>Circ. Res.</source><year>2001</year><volume>88</volume><fpage>438</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1161/01.RES.88.4.438</pub-id><pub-id pub-id-type="pmid">11230112</pub-id></element-citation></ref><ref id="B62-molecules-25-05768"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>M.A.</given-names></name><name><surname>Budish</surname><given-names>R.A.</given-names></name><name><surname>Kashyap</surname><given-names>S.</given-names></name><name><surname>Lindsey</surname><given-names>S.H.</given-names></name></person-group><article-title>GPER novel membrane oestrogen receptor</article-title><source>Clin. Sci.</source><year>2016</year><volume>130</volume><fpage>1005</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1042/CS20160114</pub-id><?supplied-pmid 27154744?><pub-id pub-id-type="pmid">27154744</pub-id></element-citation></ref><ref id="B63-molecules-25-05768"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>Q.-K.</given-names></name><name><surname>VerMeer</surname><given-names>M.</given-names></name><name><surname>Burgard</surname><given-names>M.A.</given-names></name><name><surname>Hassan</surname><given-names>A.B.</given-names></name><name><surname>Giles</surname><given-names>J.</given-names></name></person-group><article-title>Hetero-oligomeric Complex between the G Protein-coupled Estrogen Receptor 1 and the Plasma Membrane Ca2+-ATPase 4b</article-title><source>J. Biol. Chem.</source><year>2015</year><volume>290</volume><fpage>13293</fpage><lpage>13307</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.628743</pub-id><?supplied-pmid 25847233?><pub-id pub-id-type="pmid">25847233</pub-id></element-citation></ref><ref id="B64-molecules-25-05768"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayachandran</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>V.M.</given-names></name></person-group><article-title>Human platelets contain estrogen receptor alpha, caveolin-1 and estrogen receptor associated proteins</article-title><source>Platelets</source><year>2003</year><volume>14</volume><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1080/0953710031000080562</pub-id><pub-id pub-id-type="pmid">12745449</pub-id></element-citation></ref><ref id="B65-molecules-25-05768"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colman-Saizarbitoria</surname><given-names>T.</given-names></name><name><surname>Boutros</surname><given-names>P.</given-names></name><name><surname>Amesty</surname><given-names>A.</given-names></name><name><surname>Bahsas</surname><given-names>A.</given-names></name><name><surname>Mathison</surname><given-names>Y.</given-names></name><name><surname>Garrido</surname><given-names>M.R.</given-names></name><name><surname>Israel</surname><given-names>A.</given-names></name></person-group><article-title>Ferutinin stimulates nitric oxide synthase activity in median eminence of the rat</article-title><source>J. Ethnopharmacol.</source><year>2006</year><volume>106</volume><fpage>327</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.01.025</pub-id><?supplied-pmid 16574358?><pub-id pub-id-type="pmid">16574358</pub-id></element-citation></ref><ref id="B66-molecules-25-05768"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupuis</surname><given-names>M.</given-names></name><name><surname>Severin</surname><given-names>S.</given-names></name><name><surname>Noirrit-Esclassan</surname><given-names>E.</given-names></name><name><surname>Arnal</surname><given-names>J.F.</given-names></name><name><surname>Payrastre</surname><given-names>B.</given-names></name><name><surname>Val&#x000e9;ra</surname><given-names>M.C.</given-names></name></person-group><article-title>Effects of Estrogens on Platelets and Megakaryocytes</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>3111</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20123111</pub-id><?supplied-pmid 31242705?><pub-id pub-id-type="pmid">31242705</pub-id></element-citation></ref><ref id="B67-molecules-25-05768"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurbel</surname><given-names>P.A.</given-names></name><name><surname>Kuliopulos</surname><given-names>A.</given-names></name><name><surname>Tantry</surname><given-names>U.S.</given-names></name></person-group><article-title>G-Protein&#x02013;Coupled Receptors Signaling Pathways in New Antiplatelet Drug Development</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2015</year><volume>35</volume><fpage>500</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.114.303412</pub-id><pub-id pub-id-type="pmid">25633316</pub-id></element-citation></ref><ref id="B68-molecules-25-05768"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>L.B.</given-names></name><name><surname>Chandel</surname><given-names>N.S.</given-names></name></person-group><article-title>Mitochondrial reactive oxygen species and cancer</article-title><source>Cancer Metab.</source><year>2014</year><volume>2</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/2049-3002-2-17</pub-id><pub-id pub-id-type="pmid">25671107</pub-id></element-citation></ref><ref id="B69-molecules-25-05768"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madungwe</surname><given-names>N.B.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Lie</surname><given-names>M.</given-names></name><name><surname>Tombo</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Kaya</surname><given-names>F.</given-names></name><name><surname>Bopassa</surname><given-names>J.C.</given-names></name></person-group><article-title>Mitochondrial inner membrane protein (mitofilin) knockdown induces cell death by apoptosis via an AIF-PARP-dependent mechanism and cell cycle arrest</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2018</year><volume>315</volume><fpage>C28</fpage><lpage>C43</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00230.2017</pub-id><pub-id pub-id-type="pmid">29489384</pub-id></element-citation></ref><ref id="B70-molecules-25-05768"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pistritto</surname><given-names>G.</given-names></name><name><surname>Trisciuoglio</surname><given-names>D.</given-names></name><name><surname>Ceci</surname><given-names>C.</given-names></name><name><surname>Garufi</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Orazi</surname><given-names>G.</given-names></name></person-group><article-title>Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies</article-title><source>Aging</source><year>2016</year><volume>8</volume><fpage>603</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.18632/aging.100934</pub-id><pub-id pub-id-type="pmid">27019364</pub-id></element-citation></ref><ref id="B71-molecules-25-05768"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>K.J.</given-names></name><name><surname>Yang</surname><given-names>M.L.</given-names></name><name><surname>Tsai</surname><given-names>P.K.</given-names></name><name><surname>Su</surname><given-names>C.H.</given-names></name><name><surname>Chen</surname><given-names>C.H.</given-names></name><name><surname>Horng</surname><given-names>C.T.</given-names></name><name><surname>Yeh</surname><given-names>C.H.</given-names></name><name><surname>Chen</surname><given-names>W.Y.</given-names></name><name><surname>Lin</surname><given-names>M.L.</given-names></name><name><surname>Chen</surname><given-names>C.J.</given-names></name><etal/></person-group><article-title>Safrole induced cytotoxicity, DNA damage, and apoptosis in macrophages via reactive oxygen species generation and Akt phosphorylation</article-title><source>Environ. Toxicol. Pharmacol.</source><year>2018</year><volume>64</volume><fpage>94</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.etap.2018.09.012</pub-id><pub-id pub-id-type="pmid">30312850</pub-id></element-citation></ref><ref id="B72-molecules-25-05768"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.N.</given-names></name><name><surname>Jin</surname><given-names>H.O.</given-names></name><name><surname>Park</surname><given-names>J.A.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>J.Y.</given-names></name><name><surname>Kim</surname><given-names>B.</given-names></name><name><surname>Kim</surname><given-names>W.</given-names></name><name><surname>Hong</surname><given-names>S.E.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name><name><surname>Chang</surname><given-names>Y.H.</given-names></name><etal/></person-group><article-title>Heme oxygenase-1 determines the differential response of breast cancer and normal cells to piperlongumine</article-title><source>Mol. Cells</source><year>2015</year><volume>38</volume><fpage>327</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.14348/molcells.2015.2235</pub-id><?supplied-pmid 25813625?><pub-id pub-id-type="pmid">25813625</pub-id></element-citation></ref><ref id="B73-molecules-25-05768"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smithen</surname><given-names>M.</given-names></name><name><surname>Elustondo</surname><given-names>P.A.</given-names></name><name><surname>Winkfein</surname><given-names>R.</given-names></name><name><surname>Zakharian</surname><given-names>E.</given-names></name><name><surname>Abramov</surname><given-names>A.Y.</given-names></name><name><surname>Pavlov</surname><given-names>E.</given-names></name></person-group><article-title>Role of polyhydroxybutyrate in mitochondrial calcium uptake</article-title><source>Cell Calcium</source><year>2013</year><volume>54</volume><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2013.04.006</pub-id><?supplied-pmid 23702223?><pub-id pub-id-type="pmid">23702223</pub-id></element-citation></ref><ref id="B74-molecules-25-05768"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ignatkov</surname><given-names>V.I.</given-names></name><name><surname>Akhmedkhodzhaeva</surname><given-names>K.S.</given-names></name><name><surname>Babichev</surname><given-names>V.N.</given-names></name></person-group><article-title>The effect of tefestrol on the secretion of luteinizing hormone from the hypophysis</article-title><source>Farmakol. Toksikol.</source><year>1990</year><volume>53</volume><fpage>37</fpage><lpage>38</lpage></element-citation></ref><ref id="B75-molecules-25-05768"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>N.S.</given-names></name><name><surname>Sharma</surname><given-names>V.</given-names></name><name><surname>Dixit</surname><given-names>V.K.</given-names></name><name><surname>Thakur</surname><given-names>M.</given-names></name></person-group><article-title>A review on plants used for improvement of sexual performance and virility</article-title><source>Biomed. Res. Int.</source><year>2014</year><volume>2014</volume><fpage>868062</fpage><pub-id pub-id-type="doi">10.1155/2014/868062</pub-id><?supplied-pmid 25215296?><pub-id pub-id-type="pmid">25215296</pub-id></element-citation></ref><ref id="B76-molecules-25-05768"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wink</surname><given-names>D.A.</given-names></name><name><surname>Mitchell</surname><given-names>J.B.</given-names></name></person-group><article-title>Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide</article-title><source>Free Radical. Biol. Med.</source><year>1998</year><volume>25</volume><fpage>434</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/S0891-5849(98)00092-6</pub-id><pub-id pub-id-type="pmid">9741580</pub-id></element-citation></ref><ref id="B77-molecules-25-05768"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancardi</surname><given-names>D.</given-names></name><name><surname>Ridnour</surname><given-names>L.A.</given-names></name><name><surname>Thomas</surname><given-names>D.D.</given-names></name><name><surname>Katori</surname><given-names>T.</given-names></name><name><surname>Tocchetti</surname><given-names>C.G.</given-names></name><name><surname>Espey</surname><given-names>M.G.</given-names></name><name><surname>Miranda</surname><given-names>K.M.</given-names></name><name><surname>Paolocci</surname><given-names>N.</given-names></name><name><surname>Wink</surname><given-names>D.A.</given-names></name></person-group><article-title>The chemical dynamics of NO and reactive nitrogen oxides: A practical guide</article-title><source>Curr. Mol. Med.</source><year>2004</year><volume>4</volume><fpage>723</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.2174/1566524043359854</pub-id><pub-id pub-id-type="pmid">15579020</pub-id></element-citation></ref><ref id="B78-molecules-25-05768"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>R.</given-names></name><name><surname>Molina-Ruiz</surname><given-names>F.J.</given-names></name><name><surname>B&#x000e1;rcena</surname><given-names>J.A.</given-names></name><name><surname>Padilla</surname><given-names>C.A.</given-names></name><name><surname>Muntan&#x000e9;</surname><given-names>J.</given-names></name></person-group><article-title>Regulation of Cell Survival, Apoptosis, and Epithelial-to-Mesenchymal Transition by Nitric Oxide-Dependent Post-Translational Modifications</article-title><source>Antioxid. Redox Signal</source><year>2018</year><volume>29</volume><fpage>1312</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1089/ars.2017.7072</pub-id><pub-id pub-id-type="pmid">28795583</pub-id></element-citation></ref><ref id="B79-molecules-25-05768"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>P.K.</given-names></name><name><surname>Zamora</surname><given-names>R.</given-names></name><name><surname>Petrosko</surname><given-names>P.</given-names></name><name><surname>Billiar</surname><given-names>T.R.</given-names></name></person-group><article-title>The regulatory role of nitric oxide in apoptosis</article-title><source>Int. Immunopharmacol.</source><year>2001</year><volume>1</volume><fpage>1421</fpage><lpage>1441</lpage><pub-id pub-id-type="doi">10.1016/S1567-5769(01)00088-1</pub-id><pub-id pub-id-type="pmid">11515809</pub-id></element-citation></ref><ref id="B80-molecules-25-05768"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Kim</surname><given-names>C.N.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Jemmerson</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c</article-title><source>Cell</source><year>1996</year><volume>86</volume><fpage>147</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80085-9</pub-id><pub-id pub-id-type="pmid">8689682</pub-id></element-citation></ref><ref id="B81-molecules-25-05768"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamm</surname><given-names>A.</given-names></name><name><surname>Przychodzen</surname><given-names>P.</given-names></name><name><surname>Kuban-Jankowska</surname><given-names>A.</given-names></name><name><surname>Jacewicz</surname><given-names>D.</given-names></name><name><surname>Dabrowska</surname><given-names>A.M.</given-names></name><name><surname>Nussberger</surname><given-names>S.</given-names></name><name><surname>Wozniak</surname><given-names>M.</given-names></name><name><surname>Gorska-Ponikowska</surname><given-names>M.</given-names></name></person-group><article-title>Nitric oxide and its derivatives in the cancer battlefield</article-title><source>Nitric. Oxide</source><year>2019</year><volume>93</volume><fpage>102</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2019.09.005</pub-id><pub-id pub-id-type="pmid">31541733</pub-id></element-citation></ref><ref id="B82-molecules-25-05768"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>G.C.</given-names></name><name><surname>Borutaite</surname><given-names>V.</given-names></name></person-group><article-title>Nitric oxide, cytochrome c and mitochondria</article-title><source>Biochem. Soc. Symp.</source><year>1999</year><volume>66</volume><fpage>17</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1042/bss0660017</pub-id><?supplied-pmid 10989653?><pub-id pub-id-type="pmid">10989653</pub-id></element-citation></ref><ref id="B83-molecules-25-05768"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>G.C.</given-names></name><name><surname>Borutaite</surname><given-names>V.</given-names></name></person-group><article-title>Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitorsothiols</article-title><source>Bchim. Biophys Acta</source><year>2004</year><volume>1658</volume><fpage>44</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2004.03.016</pub-id></element-citation></ref><ref id="B84-molecules-25-05768"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safi</surname><given-names>R.</given-names></name><name><surname>El-Sabban</surname><given-names>M.</given-names></name><name><surname>Najjar</surname><given-names>F.</given-names></name></person-group><article-title>Ferula hermonis: A Review of Current Use and Pharmacological Studies of its Sesquiterpene Ester Ferutinin</article-title><source>Curr. Drug Targets</source><year>2020</year><volume>21</volume><fpage>499</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.2174/1389450120666191029155053</pub-id><?supplied-pmid 31663476?><pub-id pub-id-type="pmid">31663476</pub-id></element-citation></ref><ref id="B85-molecules-25-05768"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kudryavtseva</surname><given-names>A.V.</given-names></name><name><surname>Krasnov</surname><given-names>G.S.</given-names></name><name><surname>Dmitriev</surname><given-names>A.A.</given-names></name><name><surname>Alekseev</surname><given-names>B.Y.</given-names></name><name><surname>Kardymon</surname><given-names>O.L.</given-names></name><name><surname>Sadritdinova</surname><given-names>A.F.</given-names></name><name><surname>Fedorova</surname><given-names>M.S.</given-names></name><name><surname>Pokrovsky</surname><given-names>A.V.</given-names></name><name><surname>Melnikova</surname><given-names>N.V.</given-names></name><name><surname>Kaprin</surname><given-names>A.D.</given-names></name><etal/></person-group><article-title>Mitochondrial dysfunction and oxidative stress in aging and cancer</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>44879</fpage><lpage>44905</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.9821</pub-id><?supplied-pmid 27270647?><pub-id pub-id-type="pmid">27270647</pub-id></element-citation></ref><ref id="B86-molecules-25-05768"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>P.J.</given-names></name></person-group><article-title>Mitochondria, Bioenergetics and Apoptosis in Cancer</article-title><source>Trends Cancer</source><year>2017</year><volume>3</volume><fpage>857</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2017.10.006</pub-id><?supplied-pmid 29198441?><pub-id pub-id-type="pmid">29198441</pub-id></element-citation></ref><ref id="B87-molecules-25-05768"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamaraeva</surname><given-names>M.V.</given-names></name><name><surname>Hagelgans</surname><given-names>A.I.</given-names></name><name><surname>Abramov</surname><given-names>A.Y.</given-names></name><name><surname>Ternovsky</surname><given-names>V.I.</given-names></name><name><surname>Merzlyak</surname><given-names>P.G.</given-names></name><name><surname>Tashmukhamedov</surname><given-names>B.A.</given-names></name><name><surname>Saidkhodzjaev</surname><given-names>A.I.</given-names></name></person-group><article-title>Ionophoretic properties of ferutinin</article-title><source>Cell Calcium</source><year>1997</year><volume>22</volume><fpage>235</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/S0143-4160(97)90062-2</pub-id><pub-id pub-id-type="pmid">9481474</pub-id></element-citation></ref><ref id="B88-molecules-25-05768"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bano</surname><given-names>D.</given-names></name><name><surname>Prehn</surname><given-names>J.H.M.</given-names></name></person-group><article-title>Apoptosis-Inducing Factor (AIF) in Physiology and Disease: The Tale of a Repented Natural Born Killer</article-title><source>EBioMedicine</source><year>2018</year><volume>30</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2018.03.016</pub-id><?supplied-pmid 29605508?><pub-id pub-id-type="pmid">29605508</pub-id></element-citation></ref><ref id="B89-molecules-25-05768"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budd</surname><given-names>R.C.</given-names></name></person-group><article-title>Activation-induced cell death</article-title><source>Curr. Opin. Immunol.</source><year>2001</year><volume>13</volume><fpage>356</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/S0952-7915(00)00227-2</pub-id><pub-id pub-id-type="pmid">11406369</pub-id></element-citation></ref><ref id="B90-molecules-25-05768"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.</given-names></name></person-group><article-title>Mechanisms of caspase activation and inhibition during apoptosis</article-title><source>Mol. Cell</source><year>2002</year><volume>9</volume><fpage>459</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(02)00482-3</pub-id><pub-id pub-id-type="pmid">11931755</pub-id></element-citation></ref><ref id="B91-molecules-25-05768"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakeri</surname><given-names>R.</given-names></name><name><surname>Kheirollahi</surname><given-names>A.</given-names></name><name><surname>Davoodi</surname><given-names>J.</given-names></name></person-group><article-title>Apaf-1: Regulation and function in cell death</article-title><source>Biochimie</source><year>2017</year><volume>135</volume><fpage>111</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2017.02.001</pub-id><pub-id pub-id-type="pmid">28192157</pub-id></element-citation></ref><ref id="B92-molecules-25-05768"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W&#x000fc;rstle</surname><given-names>M.L.</given-names></name><name><surname>Laussmann</surname><given-names>M.A.</given-names></name><name><surname>Rehm</surname><given-names>M.</given-names></name></person-group><article-title>The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome</article-title><source>Exp. Cell Res.</source><year>2012</year><volume>318</volume><fpage>1213</fpage><lpage>1220</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2012.02.013</pub-id><?supplied-pmid 22406265?><pub-id pub-id-type="pmid">22406265</pub-id></element-citation></ref><ref id="B93-molecules-25-05768"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkhatib</surname><given-names>R.</given-names></name><name><surname>Hennebelle</surname><given-names>T.</given-names></name><name><surname>Joha</surname><given-names>S.</given-names></name><name><surname>Idziorek</surname><given-names>T.</given-names></name><name><surname>Preudhomme</surname><given-names>C.</given-names></name><name><surname>Quesnel</surname><given-names>B.</given-names></name><name><surname>Sahpaz</surname><given-names>S.</given-names></name><name><surname>Bailleul</surname><given-names>F.</given-names></name></person-group><article-title>Activity of elaeochytrin A from Ferula elaeochytris on leukemia cell lines</article-title><source>Phytochemistry</source><year>2008</year><volume>69</volume><fpage>2979</fpage><lpage>2983</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2008.09.019</pub-id><?supplied-pmid 18992904?><pub-id pub-id-type="pmid">18992904</pub-id></element-citation></ref><ref id="B94-molecules-25-05768"><label>94.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Arghiani</surname><given-names>N.</given-names></name><name><surname>Matin</surname><given-names>M.M.</given-names></name><name><surname>Bahrami</surname><given-names>A.R.</given-names></name><name><surname>Nakhaeizadeh</surname><given-names>H.</given-names></name><name><surname>Sazgarnia</surname><given-names>A.</given-names></name></person-group><article-title>Ferutinin: A Natural and Effective anti-tumour Compound</article-title><source>Proceedings of the 1st International Nastaran Cancer Symposium-2015</source><conf-loc>Mashhad, Iran</conf-loc><conf-date>1 October 2015</conf-date></element-citation></ref><ref id="B95-molecules-25-05768"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arghiani</surname><given-names>N.</given-names></name><name><surname>Matin</surname><given-names>M.M.</given-names></name><name><surname>Bahrami</surname><given-names>A.R.</given-names></name><name><surname>Iranshahi</surname><given-names>M.</given-names></name><name><surname>Sazgarnia</surname><given-names>A.</given-names></name><name><surname>Rassouli</surname><given-names>F.B.</given-names></name></person-group><article-title>Investigating anticancer properties of the sesquiterpene ferutinin on colon carcinoma cells, in vitro and in vivo</article-title><source>Life Sci.</source><year>2014</year><volume>109</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2014.06.006</pub-id><?supplied-pmid 24953605?><pub-id pub-id-type="pmid">24953605</pub-id></element-citation></ref><ref id="B96-molecules-25-05768"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lhuillier</surname><given-names>A.</given-names></name><name><surname>Fabre</surname><given-names>N.</given-names></name><name><surname>Cheble</surname><given-names>E.</given-names></name><name><surname>Oueida</surname><given-names>F.</given-names></name><name><surname>Maurel</surname><given-names>S.</given-names></name><name><surname>Valentin</surname><given-names>A.</given-names></name><name><surname>Fourast&#x000e9;</surname><given-names>I.</given-names></name><name><surname>Moulis</surname><given-names>C.</given-names></name></person-group><article-title>Daucane sesquiterpenes from Ferula hermonis</article-title><source>Nat. Prod.</source><year>2005</year><volume>68</volume><fpage>468</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1021/np049652h</pub-id></element-citation></ref><ref id="B97-molecules-25-05768"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferretti</surname><given-names>M.</given-names></name><name><surname>Cavani</surname><given-names>F.</given-names></name><name><surname>Manni</surname><given-names>P.</given-names></name><name><surname>Carnevale</surname><given-names>G.</given-names></name><name><surname>Bertoni</surname><given-names>L.</given-names></name><name><surname>Zavatti</surname><given-names>M.</given-names></name><name><surname>Palumbo</surname><given-names>C.</given-names></name></person-group><article-title>Ferutinin dose-dependent effects on uterus and mammary gland in ovariectomized rats</article-title><source>Histol. Histopathol.</source><year>2014</year><volume>29</volume><fpage>1027</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.14670/HH-29.1027</pub-id><pub-id pub-id-type="pmid">24510547</pub-id></element-citation></ref><ref id="B98-molecules-25-05768"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aydo&#x0011f;an</surname><given-names>F.</given-names></name><name><surname>Baykan</surname><given-names>S.</given-names></name><name><surname>Debele&#x000e7; B&#x000fc;t&#x000fc;ner</surname><given-names>B.</given-names></name></person-group><article-title>Cytotoxic Activity of Sesquiterpenoids Isolated from Endemic Ferula tenuissima Hub.-Mor &#x00026; Pe&#x0015f;men</article-title><source>Turk. J. Pharm. Sci.</source><year>2019</year><volume>16</volume><fpage>476</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.4274/tjps.galenos.2018.23356</pub-id><pub-id pub-id-type="pmid">32454752</pub-id></element-citation></ref><ref id="B99-molecules-25-05768"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>M.</given-names></name><name><surname>Wong</surname><given-names>S.Y.</given-names></name><name><surname>Lau</surname><given-names>P.M.</given-names></name><name><surname>Kong</surname><given-names>S.K.</given-names></name></person-group><article-title>Ferutinin induces in vitro eryptosis/erythroptosis in human erythrocytes through membrane permeabilization and calcium influx</article-title><source>Chem. Res. Toxicol.</source><year>2013</year><volume>26</volume><fpage>1218</fpage><lpage>1228</lpage><pub-id pub-id-type="doi">10.1021/tx400127w</pub-id><pub-id pub-id-type="pmid">23848973</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-05768-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The pleiotropic activities of sesquiterpene ferutinin. Ferutinin exerts several activities in human diseases, having estrogenic, anti-cancer, anti-inflammatory and bactericidal properties.</p></caption><graphic xlink:href="molecules-25-05768-g001"/></fig><fig id="molecules-25-05768-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Regulation of Wnt/&#x003b2; catenin pathway by ferutinin: ferutinin induces osteogenic differentiation of dental pulp-derived stem cells and leads to the promotion of osteoblastogenesis.</p></caption><graphic xlink:href="molecules-25-05768-g002"/></fig><fig id="molecules-25-05768-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>The ionophoric property of sesquiterpene ferutinin. Ferutinin, thanks to its ionophoric activity leads to loss of transmembrane potential and the subsequent apoptosis induction.</p></caption><graphic xlink:href="molecules-25-05768-g003"/></fig><fig id="molecules-25-05768-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Ferutinin-induced mitochondrial dysfunction: key role of ferutinin action on respiratory chain complex I and III.</p></caption><graphic xlink:href="molecules-25-05768-g004"/></fig><table-wrap id="molecules-25-05768-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-05768-t001_Table 1</object-id><label>Table 1</label><caption><p>IC50 values of different types of cell lines, tumor and healthy respectively, treated with ferutinin.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cells Treated</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC 50</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>MCF&#x02013;7:</bold> Human breast adenocarcinoma cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">81 &#x003bc;M</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B32-molecules-25-05768" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>TCC:</bold> Human Transitional Cell Carcinoma Cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">67 &#x003bc;M</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B32-molecules-25-05768" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>CT26:</bold> Murine colorectal carcinoma cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">81 &#x003bc;M</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B32-molecules-25-05768" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>HT29:</bold> Human colorectal adenocarcinoma cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">72 &#x003bc;M</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B32-molecules-25-05768" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>K562R:</bold> Human chronic myeloid leukemia cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">25.3 &#x003bc;M</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B93-molecules-25-05768" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>DA1-3b/M2BCR-ABL:</bold> Mouse leukemia cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">29.1 &#x003bc;M</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B93-molecules-25-05768" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>NTERA2:</bold> Human teratocarcinoma cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">39 &#x003bc;M</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B94-molecules-25-05768" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>KYSE30:</bold> Human oesophageal cancer cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">58 &#x003bc;M</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B94-molecules-25-05768" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>PC3:</bold> Prostate cancer cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">16.7 &#x003bc;M</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B98-molecules-25-05768" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>HFF3:</bold> Human foreskin fibroblast cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">98 &#x003bc;M</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B32-molecules-25-05768" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>NIH/3T3:</bold> Mouse embryo fibroblast cell line</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">136 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-molecules-25-05768" ref-type="bibr">32</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>